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k 103 m 10-3 \i - 10-6
n 10-9 P 10-12 f - 10-15
bp - base pairs kb kilo base pairs
A Amperes V Volts
W Watts Ci Curies
°c degrees Centigrade g grammes
1 litres m metres
M molar mol moles
h hours min minutes
sec seconds rpm revolutions per minute
cps counts per second cpm - counts per minute
Chemicals/Reagents.
APS - ammonium persulphate
ATP - adenosine triphosphate
DNase I - deoxyribonuclease I
dNTP - deoxynucleoside triphosphate
DTT - dithiothreitol
EDTA - ethylenediaminetetraacetic acid (disodium salt)
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IPTG - isopropyl P-D-thiogalactopyranoside
RHB - resolvase dilution buffer
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TMED - A,A,A’,A’-tetramethylethylenediamine
Tris - tris-fhvdroxvmethvl)aminoethane
Other Terms
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Summary
Prior to this work, no mutants of Tn3 resolvase had been isolated. To construct a variety 
of mutants, a suitable plasmid for mutagenesis purposes was created. This plasmid, pAT5, 
contains unique restriction sites along two thirds of the length of the resolvase open reading 
frame. This allows double stranded oligonucleotides containing mutations to be cloned into 
the resolvase gene. pAT5 was also designed to be compatible with the galK screen used to 
investigate the in vivo properties of the mutants. The in vivo assay was based on change of 
colony colour on MacConkey agar plates when the cells were unable to utilise galactose, 
due to the deletion of a plasmid-encoded galK gene by resolvase-catalysed recombination.
Two specific mutants of TnJ resolvase were made, Y6F and E124Q. Random mutagenesis 
of the E-helix of resolvase created a library of mutants, which was screened in vivo for 
ability to resolve test plasmids containing either two res sites, or two isolated copies of 
binding site I of res (the crossover site) or one site I and one res. The mutant resolvase 
D102Y was isolated, which promoted the reaction between res v site I in vivo.
In order to purify these and any subsequent mutants, a new purification procedure was 
developed. This is a denaturing protocol which has been shown to be reproducible for 
wild-type resolvase and the mutants mentioned above. A new expression plasmid, using a 
promoter recognised by the phage T7 RNA polymerase was created, resulting in higher 
yields of resolvase per gram of cells.
In vitro analysis of Y6F resolvase showed that the protein was recombinationally inactive 
on a wild type substrate, but retained binding ability as well as cleavage and religation 
activities. This supports the theory that resolvase linkage to the DNA during recombination 
is by a phosphoseryl, and not a phosphotyrosyl linkage as in topoisomerases.
L69F mutant resolvase, inadvertently created during the construction of the mutant selection 
system, retains recombination activity, but displays topoisomerase activity and aberrations 
in binding.
ix
The TnJ resolvase mutant E124Q was observed to display enhanced cleavage activity, but 
unlike the y8 E124Q resolvase mutant does not show the ability to resolve substrates 
containing partial res sites.
The mutant isolated using the in vivo screen, D102Y resolvase, was shown to display the 
same phenotype in vitro as in vivo, and catalysed recombination between res and site I. 
This protein also catalyses intermolecular reactions, and may be described as having a 
"hyperactive" phenotype. The isolation of a mutant resolvase with this phenotype is a 
major step towards the isolation of a mutant able to catalyse a recombination reaction 
between two site I's.
Chapter 1
Introduction
1Introduction
1.1 Features of site-specific recombination
Site specific recombination causes DNA rearrangements in a precise and controlled 
manner by the breakage and rejoining of the DNA at specific sites. The recombination 
reactions have no requirement for extensive homology between the DNA segments 
involved, unlike general recombination, but are instead characterised by the highly 
specific nature of the DNA sites and their interactions. Some of the essential in vivo 
functions of this method of recombination include the control of gene expression, 
resolution of intermediates of transposition, the regulation of plasmid copy number, and 
the integration and excision of bacteriophage DNA from the host chromosome 
(Matthews, 1992; Stark et al., 1992; Johnson, 1991).
The strand exchange reaction is catalysed by the recombinase protein, specific to the 
recombination system, although other accessory proteins may be involved. The 
recombinase binds to the recombination site, and subsequently mediates strand cleavage, 
exchange and religation, such that there is no loss or synthesis of DNA. The outcome of 
this event is dependent on the positioning and orientation of the sites involved. In 
prokaryotic systems, where recombination usually occurs on circular plasmid substrates, 
an intermolecular reaction (between sites on different DNA molecules) results in the 
fusion of two molecules, while intramolecular reactions (between sites on the same 
molecule) can have one of two outcomes (see Figure 1.1). Since recombination between 
identical sites results in linking of the right half of one site to the left half of the second 
site, thus preserving the sequence of the sites, recombination sites which exist in inverted 
repeat result in the inversion of the DNA sequence with respect to the rest of the DNA 
molecule, while sites in direct repeat result in the resolution of the plasmid DNA.
Most of the known site specific recombination systems can be divided into two families 
based on sequence homology of the recombinase; the resolvase/invertase family 
(exemplified by TnJ resolvase), and the integrase family (exemplified by the 
bacteriophage X integrase). Members of these families also share similarities in their 
recombination sites and reaction mechanisms.
(a)
B
Resolution 
 ►
(Fusion)
B
(b)
Inversion
Figure 1.1. Diagram illustrating resolution and inversion.
(a) Resolution of a circular substrate containing two directly repeated sites. 
The reverse reaction is fusion.
(b) Inversion of a circular substrate containing two inverted repeat sites.
Recombination sites are indicated by blank or shaded boxes, with arrow 
heads to show their orientation, defined by sequence asymmetry. A and B 
are sequence markers, e.g. restriction endonuclease recognition sites. 
Figure adapted from Blake, 1993.
21.2 The integrase family
Recombination by the integrase family of recombinases is characterised by a two step 
reaction in which each step involves the cutting and rejoining of two strands of DNA. In 
the first step, one strand of each DNA double helix in the two recombining sites is 
nicked, and strand exchange occurs producing a crossed strand Holliday intermediate 
(equivalent to the Holliday structure of general recombination). The second step in the 
reaction involves the resolution of the Holliday intermediate by exchange of the second 
pair of strands (see Figure 1.2).
Members of the integrase family of recombinases are diverse, with molecular weights 
ranging from 20-65 kDa, and low sequence conservation. The protein-DNA linkage 
during strand transfer is via a phosphotyrosine bond. This differs from resolvase family 
recombinases, which become linked to the DNA via a phosphoserine bond.
Several Int-like systems have been studied extensively in vitro; particularly X Int, /ox/Cre, 
Xer and FLP (A. Landy, 1989; Hamilton and Abremski, 1984; Sherratt et al., 1993;
Cox, 1989).
1.3 The resolvase/invertase family
As well as Tni resolvase, this family includes recombinases encoded by many other 
transposons, such as y8 (also known as TnlOOO) and Tn27. Tn3 and yS resolvases are 
very similar in sequence, and as such features of the Tn3 system are generally applicable 
to the y8 system and vice versa. The DNA invertases, such as the phage Mu encoded 
Gin, while on the surface very different to the resolvase family, also contain many 
features in common with them which will be discussed throughout this Chapter. Other 
related recombinases have functions in bacteriophage integration, plasmid 
monomerisation, and programmed developmental genetic rearrangements.
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31.4 Tn3 resolvase
Transposition of Tn3 is a two step process mediated by two distinct proteins. The first 
of these, transposase, is the product of the tnpA gene. Transposase mediates 
intermolecular replicative transposition, which results in the fusion of donor and target 
molecules, and the replication of the transposon. Resolvase, the product of the tnpR 
gene, then directs recombination between specific sites, res, on each transposon in the 
intermediate “cointegrate” molecule. This results in discrete donor and recipient 
molecules, each retaining a copy of the transposon (Figure 1.3a). Subsequent to 
resolution, the donor and recipient molecules, which exist as a singly linked catenane, are 
separated in vivo by the action of a type II topoisomerase (e.g. DNA gyrase). Tn3 is 
4957 bp long, and as well as the tnpA and tnpR genes, the transposon confers P-lactam 
resistance to the host E. coli cell by its Bla gene (Figure 1.3a). Tn3 is one of a group of 
related ampicillin resistance encoding transposons which exist in enteric bacteria. These 
retain 90% sequence similarity and a high level of functional similarity (reviewed in 
Sherratt, 1989).
As originally shown by DNase I footprinting, the region of y8 transposon required for 
recombination (res) contains three binding sites for resolvase (Grindley et al., 1982), each 
of which binds a dimer of the protein (reviewed in Hatfull and Grindley, 1988; see Figure 
1.3b). In Tn3, the very similar res site is 114 bp in length and comprises three binding 
sites of unequal length and uneven spacing, but which retain sequence similarity and 
imperfect dyad symmetry. Each binding site contains a pair of 9 bp inverted repeats 
which span a central spacer of 10 bp in site I, 16 bp in site II and 7 bp in site III. The 
precise spacing between the centre of site I and II (53 bp) is essential for efficient 
recombination. The insertion of a non-integral number of helical turns in the 22 bp spacer 
sequence between sites I and II results in very poor recombination, while the addition of 
1 or 2 integral turns has less effect on the recombinational activity (Hatfull and Grindley, 
1988).
Each site within res binds a dimer of resolvase. One noted difference between TnJ and 
yp resolvases is that, while Tn3 resolvase binds first as a monomer and dimerises on 
binding to the res site, y8 resolvase has been shown to bind mainly as a dimer in gel shift
(a)
Tn 3 
►
Donor
ransposase
Recipient
Tn3 
(4957 bp)
res
tnpA ^  tnpR 31a
i
Transposase
1 I
Resolvase B-lactamase 
(Apr)
Donor
Resolvase
Co-integrate
Type II 
topoisomerase
Recipient
(b)
Site I 
28 bp 22 bp
Site II 
34 bp
Site III 
5 bp 25 bP
Figure 1.3 Transposon Tn3 and res.
(a) Structure of Tni. Terminal inverted repeats are denoted by small 
arrows. Genes and corresponding gene products are indicated. 
Replicative transposition of Tn3 is illustrated. The relative orientations 
of the Tn3 elements are indicated by arrowheads. The transposition step 
requires DNA polymerase for replication of Tn3, and the resolution step 
requires DNA gyrase to decatenate the products of co-integrate 
resolution.
(b) Structure of Tn3 res. Sites I, II and III are indicated by boxes, and 
the position of DNA cleavage by resolvase is also shown. The imperfect 
inverted repeat sequences at the outer arms of each site are represented 
by arrowheads. The positions at which resolvase becomes covalently 
linked to the DNA are indicated. Figure adapted from Blake, 1993
4assays (Blake et al., 1995). Resolvase binds co-operatively, with the strongest 
interactions at the outer ends of the consensus sequence of each binding site in the major 
groove of the DNA, made by the helix-tum-helix binding motif (Yang and Steitz, 1995).
Resolvase has been shown to induce a 2 bp staggered cleavage at the centre of site I 
within a region of perfect dyad symmetry, the central AT dinucleotide of the sequence 
TTATAA (Reed and Grindley, 1981; Mcllwraith et al., 1995). Cleavage results in 2 bp 
3' extensions around which strand exchange and religation take place (Figure 1.3b).
In order for cleavage at site I to take place, sites II and III, the so-called accessory sites, 
are required to be present (Bednarz et al., 1990). These sites are thought to play an 
essential role in synapsis, creating the required topology for recombination to take place 
(Watson etal., 1996).
The Tn3 family of resolvases are approximately 185 amino acids (20.5 kDa) in length, 
and display extensive sequence similarity within the subfamily, as well as having 
similarity to the Cin, Gin, Hin and Pin invertases. The proteins have a classical helix- 
turn-helix motif which is similar to that found in a variety of other DNA-binding proteins, 
such as Cro and cl of bacteriophage lambda. Tn3 and y8 resolvases have been shown to 
be functionally interchangeable; that is, Tn5 resolvase will promote recombination at yS 
res sites, and vice versa. Cleavage of these resolvases with chymotrypsin results in two 
proteolytic fragments, a 5 kDa C-terminal domain and a 15.5 kDa N-terminal domain 
(Abdel-Meguid et al., 1984). These fragments were shown by footprinting to bind on 
opposite sides of the DNA helix (Mazzarelli et al., 1993).
The C-terminal fragment comprises 45 amino acids, and contains the helix-tum-helix 
motif responsible for binding resolvase to the consensus sequences of the inverted repeats 
of each res site. Mutations in y8 resolvase C-terminal region have been shown to impair 
or abolish binding of the protein to its site (Rimphanitchayakit and Grindley, 1990).
The amino terminal fragment of resolvase, of 140 amino acids, is thought to mediate the 
protein interactions between the resolvase monomers, as well as containing the residues 
responsible for forming the catalytic site (Abdel-Meguid et al., 1984; Hughes et al.,
51990). Lambda family integrases and topoisomerases cleave the DNA forming a 
phosphotyrosine linkage with the DNA. However, existing evidence points to the serine 
at position 10 as providing the nucleophile for the resolvase reaction, resulting in the 
formation of a phosphoserine bond at the crossover point (Reed and Moser, 1984;
Klippel et al., 1988a). The protein is covalently linked to the 5' recessed DNA ends.
This serine residue is completely conserved throughout the entire resolvase family. 
Mutational studies in yS resolvase and Gin invertase have shown a loss of recombination 
when serine at position 10 is replaced. The resolvase family do also contain an entirely 
conserved tyrosine (at position 6 in TnJ resolvase). Although this residue has been 
shown to be important in catalysis (Leschziner et al., 1995; see Chapter 6), it is 
apparently not the nucleophile required for strand cleavage.
Mutations of a variety of other residues, as well as Tyr-6 and Ser-10, have been shown to 
abolish recombination, e.g. at Gin-14, Asp-36, Gln-40 and Asp-67 (Hughes et al., 1990; 
Leschziner et al., 1995; Boocock et al., 1995). These mutant resolvases retain binding 
activity but are deficient in recombination. These residues are therefore thought to be also 
important for catalysis.
The initial crystal structure of y8 resolvase, at 2.7 A resolution determined the structure of 
the N-terminal but not the C-terminal domain, which remained disordered (Sanderson et 
al., 1990). This disorder was seen as indicating potential flexibility within the protein, 
which may account for the comparable binding of resolvase to all three res binding sites 
even though the spacing of the motifs recognised by the C-terminal domain varies 
between the sites. The structure shows that the first 120 amino acids of the N-terminal 
domain form a central 5-stranded p-pleated sheet surrounded by five a-helices. The Ser- 
10 is exposed. The crystal structure (later refined at 2.3 A; Rice and Steitz, 1994b) has 
shown that of the 4 dyad related dimers observed, the interface formed by the pairing of 
the C-terminal helices (the E-helices) of the domain (the 1,2 dimer interface), is the only 
one formed by all monomers, and the relevant dimer interface in resolvase binding in 
solution (Hughes et al., 1990, 1993). This interface is hydrophobic in nature and has 
several conserved hydrophobic residues at its centre.
61.5 Resolvase bound to res
Resolvase has been shown to induce bending of the DNA when it is bound at each of the 
three res sites. Bending induced at site I of the DNA has been shown to be different from 
the bending induced at sites II and III; this may be due to the structural distortion of the 
DNA required at the crossover site. It has been shown that sites I and II of res have to be 
in the correct phase. Cleavage studies with DNase I suggest that the DNA in a fully 
bound res site is looped, possibly through dimer-dimer interactions of resolvase at sites I 
and III (Hatfull etal., 1987).
Fis-independent Gin mutants have been observed to unwind the DNA at the crossover 
point (Klippel et al., 1993). This is not the case with wild-type Gin, but is thought to be 
induced by the interactions of Fis with paired recombination sites. This may aid strand 
exchange by disruption of base pairing at the crossover site. There has also been 
evidence to show that y8 resolvase can cause a structural anomaly in the DNA at the 
centre of site I (Hatfull etal., 1987).
The relationship between the structure of resolvase bound to the res site (the 
resolvosome), and the synaptic structure (the synaptosome) is unclear. Interactions in a 
single res complex may require to be broken before formation of the synaptic complex 
can occur. But mutants which cannot form a resolvosome are also deficient in 
recombination, and therefore some of the interactions in the resolvosome are still present 
in the synaptic complex or as a necessary prelude to or requirement for synapsis.
The co-crystal structure solved at 3.0 A resolution of a dimer of y8 resolvase bound at res 
site I showed a 1,2 dimer of resolvase bound to a symmetrical site I oligonucleotide 
(Yang and Steitz, 1995). The entire 28 bp of site I is encircled by the protein. Site I 
DNA is bent at 60° towards the major groove and away from the N-terminal domains.
The DNA is also bent towards protein sequences at the ends of the site bound in the major 
groove by the helix-tum-helix motif in the C-terminal domain (Yang and Steitz, 1995; 
Figure 1.4).
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7The E-helix of one monomer of the resolvase dimer is straight, while the second is bent at 
26° into the minor groove. The protein is therefore displaying a degree of asymmetry in 
the dimer subunits, which may be relevant to the flexibility of the protein in binding to the 
different sites within res.
The active Ser-10 residues are more than 30 A apart, while the two scissile bonds at the 
central dinucleotide are only 13 A apart. Concerted double stranded cleavage is therefore 
not feasible in this complex. It suggests that either a conformational change, or sequential 
single stranded cleavage must take place in order to allow the necessary interactions to 
occur. As yet no dimer-dimer interface has been identified. Therefore, we cannot at 
present distinguish between two very different models for synapsis of two site I’s; the 
DNA duplexes may be close together, with the N-terminal domains of resolvase on the 
outside of the synaptic complex, or the N-terminal domains could make a dimer of dimers 
with the DNA on the outside (Figure 1.5).
Resolvase bound at site II is in a quite different configuration from that bound at site I 
(Blake et al., 1995). In particular, the two subunits of the dimer interact with the DNA in 
a different geometry.
1.6 In vitro resolution
The in vitro reaction requires only the presence of a substrate (supercoiled and containing 
two res sites in direct repeat), the protein resolvase and a simple buffer. Cleavage of the 
DNA and the subsequent strand exchange occur at the centre of site I (Reed and Grindley, 
1981). This is thought to be by a double stranded break at the central AT dinucleotide, 
giving 2 bp 3' extensions. A 5' phosphoserine bond then joins res to resolvase. This 
protein/DNA bond is broken on the religation of the DNA ends in the recombinant 
configuration (Reed and Grindley, 1981; Reed and Moser, 1984). The product of the in 
vitro recombination reaction is a (-2) catenane. This is also the in vivo product, though 
the linkage of the two circles of the catenane is separated afterwards by the action of DNA 
gyrase, or another type II topoisomerase (Bliska et al., 1991).
Figure 1.5 Illustration of two different types of synaptic structure.
Resolvase monomers are represented by spheres, and site I DNA by 
thick or thin lines.
(a) Sites come together with the catalytic domains of resolvase at the centre of 
the synaptic complex, as predicted by the subunit rotation model of strand 
exchange (see Section 1.8).
(b) Structure in which the DNA is at the centre of the synaptic complex and 
the resolvase monomers are on the outside, as predicted in the DNA-mediated 
model of strand exchange (see Section 1.8). Figure adapted from Rice and 
Steitz, 1994a.
8The specificity of this product reflects the topological selectivity of the recombination 
reaction. Exactly three negative inter-domainal nodes are trapped between the sites in the 
synaptic complex and strand exchange has a right handed sense. A linkage change of +4 
occurs during Tn3 resolution, and this is reflected in the reverse reaction where a linkage 
change of -4 is observed (Boocock et al., 1987; Stark et al., 1989b). This change is 
consistent with the plectonemic wrapping of the DNA/res sites and a “simple rotation” 
mechanism of strand exchange (Stark et al., 1989b). Extensive further studies of the 
topology of the reaction are also consistent with these notions (Stark and Boocock, 
1995a). Topological selectivity has also been observed in the Xer recombination system 
where 3 negative supercoil nodes are also apparently trapped between the recombining 
sites (Colloms et al., 1997), and in Gin/Hin inversion.
The reaction is very specific for recombination between res sites in direct repeat. No 
recombination has been found to occur between res sites on different molecules or 
between sites in inverted repeat on supercoiled molecules. This is consistent with the 
theory of topological constraints which exist within the system.
1.7 Synapsis, and proposed models for it
It is as yet unclear exactly how the two res sites align themselves to form the synaptic 
complex while retaining the topological selectivity required for the reaction. A variety of 
models for the mechanisms leading to synapsis, and the structure of the synaptic complex 
itself have been proposed (reviewed in Stark and Boocock, 1995a).
The tracking mechanism proposes that resolvase bound at a res site diffuses along the 
adjacent DNA until it aligns itself with a second site. This method explains the strong 
bias within the system against recombination between inverted sites, and intermolecular 
reactions. However, the random segregation of “reporter rings” linked to the substrate 
between the two circles of the resolution product makes it difficult to accept this model of 
synapsis (Benjamin and Cozzarelli, 1986). Further evidence against the model was its 
inability to account for reactions showing the occurrence of recombination between a res 
site on a linear molecule and a second res site on a supercoiled plasmid, and of
9recombination between res sites present on separate circles of a catenane (Boocock et al., 
1987).
Slithering makes use of the knowledge that supercoiled DNA is plectonemically wound, 
and that as such it might move so that sites can be brought together in a defined synapse 
(Benjamin and Cozzarelli, 1986). This type of DNA movement has not been proved 
experimentally, and slithering does not account for the evidence that resolvase bound to a 
linear site can react intermolecularly with a supercoiled substrate (Brown, 1986; Boocock 
et al., 1987). It has also been shown that recombination of a relaxed substrate results in 
the same (-2) catenane as that produced when recombination occurs within a supercoiled 
substrate (Boocock et al., 1986). This means that recombination in these two cases 
would have to occur by drastically different mechanisms and yet result in the same 
product, which is unlikely.
In the model known as 2 step synapsis, the res sites come together by random collision, 
but require the presence of a topological filter to ensure that strand exchange will only 
occur in a defined productive synapse (Boocock et al., 1986, 1987; Stark et al., 1989a). 
The random collision by which it is proposed that the res sites come together results in a 
variety of synaptic structures. However, only one of these structures is energetically 
favourable such that the next stage in recombination, strand exchange, may take place 
(Figure 1.6). The requirement for a productive synapse is the trapping of three inter- 
domainal nodes between the crossover sites (Stark et al., 1989b). Other collisions, such 
as those occurring between inverted sites, would result in a synapse which is tangled, and 
energetically unfavourable to the next step in the reaction. These unfavourable synapses 
would then rapidly dissociate to allow the possibility of forming the more energetically 
favourable productive synapse. The trapping of the three inter-domainal nodes is thought 
to be brought about by the wrapping of sites II and IH from each site in an antiparallel 
alignment, with the formation of tetrameric resolvase structures. This is followed by the 
alignment of site I's (hence the “two”-steps). This model relies heavily on the presence 
of sites II and HI to perform the necessary wrapping to bring about correct alignment, and 
it has been shown that correct alignment of site I’s only takes place in the presence of 
these accessory sites (Bednarz et al., 1990). Substrates lacking sites II and III were 
shown to perform recombination (very inefficiently) with both parallel and antiparallel
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alignments of the two site I's. It has also been shown that res sites form a synapse when 
present in inverted repeat (Benjamin and Cozzarelli, 1988; Watson, 1994). However the 
synapse formed is not productive, and does not proceed through the remainder of the 
reaction. This supports the evidence for a topological filter, since these unproductive 
synapses can be formed but lack a necessary requirement, such as the correct topology to 
proceed through strand exchange.
In the two-step synapsis model, a highly simplified structural model of the synapse was 
proposed in which the antiparallel-aligned pair of sites II/TII is wrapped around two 
resolvase tetramers formed by interactions of dimers bound to individual sites, and 
resolvase dimers bound at site I interact to make another tetramer (see Figure 1.6). Other 
more elaborate models have been put forward, incorporating some of the structural data 
(Rice and Steitz, 1994b; Boocock et al., 1995; Yang and Steitz, 1995). However, since 
no sound relevant biochemical or crystallographic data are as yet available, all such 
models are at present speculative.
Comparisons have been drawn between resolvase bound at the accessory sites and the Fis 
protein bound at the enhancer of the inversion systems of Gin and Hin. These inversion 
systems do not have accessory sites next to the crossover site, but instead require the 
presence of an intramolecular enhancer sequence bound by Fis for efficient 
recombination. It has been proposed that synapsis requires Fis-bound enhancer and Gin- 
bound gix sites (or Hin-bound hix sites) in an interactive invertasome. A role of the 
enhancer has been suggested to be in inducing a conformational change in order to 
unwind the DNA at the crossover site and allow cleavage to take place (Klippel et al., 
1993). Gin mutants which can act in the absence of Fis and the enhancer have been 
shown to mediate normal inversion, as well as displaying the ability to carry out deletion 
and intermolecular fusion. This suggests a loss of specificity of the topological filter, 
which may be defined by the Fis-bound enhancer and analogously, the accessory sites II 
and III of resolvase. The mutants do indeed give topologically complex “random 
collision” products of recombination. These mutants will be discussed later (in Section
1.9).
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1.8 Cleavage and strand exchange
The formation of a productive synapse leads to cleavage of the DNA at the centre of site I. 
Concerted double strand cleavage has been widely accepted as a fact for the 
resolvase/invertase family (Reed and Grindley, 1981; Boocock et al., 1995; reviewed in 
Stark and Boocock, 1995b). Evidence to support this has been the total lack of 
experimental evidence of a Holliday structure, which, if single strand cuts were made in 
each duplex, would presumably be formed during the strand exchange process. Further 
evidence for double strand breakage has come from the in vitro isolation, using modified 
conditions, of both y5 resolvase and Tn3 resolvase-res complexes. These complexes 
show double strand cuts present in the DNA at each res site (Reed and Moser, 1986; 
Mcflwraith, 1995). Recent crystallographic and biochemical observations have 
highlighted that concerted double strand cleavage may not be such an open and shut case. 
The crystal structure of y5 resolvase bound at site I (Yang and Steitz, 1995) shows the 
Ser-10 residues, which act as the nucleophile during the reaction, to be too far apart from 
the cleavage position, the central dinucleotide of site I, for concerted double strand 
cleavage. This demands that a large conformational change must take place to allow 
double strand cleavage. When this is taken into account, along with the asymmetry of the 
protein, which suggests that the monomers comprising the dimer may act independently, 
there surely exists reasonable doubt. Recent studies using mutant resolvases have shown 
that single strand breakages can be generated (Boocock et al., 1995). Cleavages may not 
be truly concerted, but strand exchange might nevertheless have a requirement for two 
doubie strand breakages i.e. all four strands to be cleaved, before strand exchange takes 
place (Yang and Steitz, 1995). It has been shown that the catalytic residues of y6 
resolvase act in cis, cleaving the DNA strand to which they are bound, and that there is no 
required order to strand cleavage (Boocock et al., 1995).
Models for strand exchange must be in accord with the current information we possess in 
order to be considered feasible. The linkage change, the change in the number of helical 
turns of the DNA double helix, in going from the substrate to the product, helped 
distinguish between possible mechanisms. The linkage change of Tni resolution was 
found to be +4 in the forward and -4 in the reverse reactions. This information can be 
combined with the knowledge that the topology of the product is a (-2) catenane, and that
12
synapsis creates three negative inter-domainal nodes. This information discounts the 
possibility of simply breaking and rejoining the paired res sites, or recombination through 
a Holliday junction, since these do not account for the topological changes from the 
substrate to the product (Stark et al., 1989b).
Changes in DNA topology and the fact that four strand cleavages occur prior to strand 
exchange are consistent with a model for strand exchange known as subunit rotation 
(Stark et al., 1992). In this model, the tetramer of resolvase at site I causes double strand 
cleavage at both crossover sites. Each monomer of resolvase is covalently attached to the 
half site to which it is bound. One dimer then rotates, along with its attached half site, 
through 180° in a right handed sense, resulting in the recombinant configuration (Figure 
1.7). Religation of the strands and dissociation of the catenane then follows.
This model, as well as being consistent with the topological evidence discussed above, 
also accounts for minor products formed during the reaction. Further rounds of 180° 
rotation, in the absence of religation, would account for the 4 noded knot, 5 noded 
catenane and 6 noded knots observed (Stark and Boocock, 1994; Figure 1.8).
However, as yet no direct biochemical or physical evidence has been shown to support 
this model, and it must be noted that the model requires a large movement of the 
DNA/protein complex and the breakage of dimer interactions before rotation can occur. 
Other models, which do not require subunit rearrangement have been proposed (Rice and 
Steitz, 1994a; Boocock et a l, manuscript in preparation). The Rice and Steitz model 
proposes that the two site I DNA’s are bound to resolvase dimers and are brought 
together such that the crossover points are in close proximity. Strand exchange then 
occurs with only relatively minor movement of the DNA (see also Chapter 7; see Figure
1.9).
1.9 Mutational studies
Recombination between gix sites of phage Mu requires the Gin protein bound at these 
sites and in addition an enhancer sequence bound by the host factor Fis. Mutants have
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(a) Subunit rotation
(b) DNA-mediated
(c) Catalytic domain rotation
Figure 1.9 Models of resolvase-mediated strand exchange.
Only site I DNA is shown for simplicity. Crossover half-sites are shown as 
white or shaded rectangles. The resolvase N- and C-terminal domains are shown as 
large and small circles respectively in (a) and (b).
(a) Subunit rotation. Half-sites are exchanged by rotating one pair of subunits (along 
with its attached half-sites) relative to the other pair.
(b) The DNA-mediated model proposes that strand exchange occurs via 
movement of the free 3'-hydroxyls, without rearrangement of the bound 
resolvase dimers (Rice and Steitz, 1994a).
(c)The complexity of this model made it necessary to show the C-terminal 
and N-terminal domains ("C" and "N" respectively) and the E-helix
(denoted by "E"). This model proposes that a flexible hinge exists between the E-helix 
and the N-terminal domain, which allows rotation of the N-terminal domains 
without dissociation of the 1,2 dimer (M. R. Boocock et al., manuscript in preparation).
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been isolated and investigated in vitro, which promote deletion and intermolecular fusion, 
as well as inversion in the absence of the enhancer-Fis (Klippel et al., 1988b, 1993).
A model for Gin recombination proposes that the gix sites bound by Gin come together 
with the protein Fis bound at the enhancer at a branch point in a negatively supercoiled 
DNA substrate. This nucleoprotein complex traps two negative supercoils between the 
gix sites. Strand exchange then occurs after staggered double stranded breaks at each gix 
site. One pair of half-sites rotates about the other, and the DNA is religated. This wild- 
type reaction has a strict specificity for inversion (Figure 1.10).
As well as inversion, relaxation of the substrate is brought about by wild-type Gin, on the 
formation of the synaptic complex. Gin mutants have been isolated which do not have 
this pre-requisite and promote relaxation in the presence of a single gix site where no 
synaptic complex could be formed (Klippel et al., 1988b). This was observed not to be 
by random topoisomerase activity, since substrates lacking any gix sites were not relaxed. 
Therefore, mutant Gin was able to break DNA at a gix site, pass a second DNA segment 
through the break, and rejoin the DNA without the enhancer, Fis or a second gix site on 
the same substrate molecule.
Under specific conditions, recombination by mutant Gin was found to be 20% in the 
absence and 30% in the presence of Fis. Analysis of the linkage change showed that 
60% of the recombinant products had a linkage change of +4, indicating that they were 
formed through the same pathway as the wild-type reaction, though up to 40% of 
products had proceeded though a different synaptic complex resulting in a linkage change 
of 0, indicating that no supercoils had been trapped during the reaction (Klippel et a l, 
1993).
The Gin mutants were also found to catalyse intermolecular recombination. Analysis of 
this reaction showed that recombination proceeded through complexes formed by a 
parallel or antiparallel alignment of the gix sites. This seems to indicate that the crossover 
sequence and the sequence outside the gix sites is not important in the determination of 
the site alignment. Mutant Gin was shown to mediate strand exchange in both the right 
and left handed sense, probably through the 0-synaptic complex (trapping no topological
Synapsed structure
Free structure
Circle
Circle with inverted domain
Figure 1.10 Topological changes during recombination by 
wild-type Gin.
The arrows represent the gix sites, and the thick and thin lines 
represent the domains between them. The substrate is shown with only the 
two essential negative interdomainal nodes. The upper row shows the 
protein-bound synapsed structures and the lower row shows the free 
unfolded forms. The enhancer is illustrated by a white box. Figure adapted 
fromKanaar etal., 1988.
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nodes) with parallel or antiparallel sites. It is negative supercoiling which imposes right 
handed directionality on wild-type strand exchange (Klippel et al., 1993).
Binding studies have shown that mutant Gin protects both gix half sites, but in a different 
manner from the wild type protein. Wild-type Gin protects all but the 2 bp staggered 
crossover, while mutant Gin leaves an unprotected region of up to 4-5 bp. Mutant Gin 
altered the DNA structure such that footprinting studies showed an increased accessibility 
of MPE.Fe(E) (the iron chelate of methidium propyl EDTA, which cleaves the DNA 
while intercalating via the minor groove) in the minor groove in the region of strand 
exchange. This was found to be due to a localised unwinding of approximately half a 
helical turn per gix site.
The proposed role of the Fis/enhancer complex is that it induces a conformational change 
in the GinI gix complex such that cleavage and strand exchange may proceed. This may 
result in partial unwinding at the gix site (Klippel et a l, 1993).
These mutants of Gin, H106Y and M l 14V , have been modelled on the y5 resolvase 
crystal structure, and are in the E-helix constituting the dimer interface in solution. The 
changes could change the relative positions of the monomers and thus rotate the half sites 
bound by them, unwinding the DNA at the centre of gix. Unwinding may be required to 
dismpt base pairing at the crossover region, and may help place the serines into a more 
favourable position for attacking the DNA.
To learn more about these mutants, secondary mutations which suppress the Fis- 
independent phenotype were isolated (Merker et al., 1993). Secondary mutations which 
suppressed the Fis independent phenotype of the Gin mutant Ml 14V were screened for, 
and 9 single mutations were found to revert the phenotype to wild-type. Separation of 
these mutants from Ml 14V showed that they all caused the protein to be 
recombinationally inactive. Most of these mutants were located within 10 amino acids of 
the amino terminal of the protein. The corresponding region in y8 resolvase has yielded 
recombinationally inactive y5 resolvase mutants, shown to be defective in dimer-dimer 
interactions (Hughes et al., 1990).
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Mutants of the Cin recombinase have also been isolated which efficiently recombine in the 
absence of the enhancer, and like Gin Ml 14V have a relaxed phenotype, promoting 
reaction between cix sites on separate molecules and between sites in direct repeat 
(Haffter and Bickle, 1988). These mutants, R71H and H106Y, unlike the Gin mutants, 
have a requirement for the presence of Fis. These mutants support the idea that the 
enhancer defines the topological specificity of the synaptic complex. The loss of 
enhancer dependence is the reason that these mutants have acquired the ability to 
recombine sites in direct repeat and sites on different molecules.
Mutants of y5 resolvase have been used to investigate the synaptic structure, and the role 
and requirements of the accessory sites II and IE in comparison to the catalytic site I. 
Studies using combinations of specific mutants have shown that the requirements for 
resolvase when bound at site I are different from when the protein is bound at the 
accessory sites (Grindley, 1993). Resolvase bound at site I has a requirement for Ser-10. 
The mutant SIOL, which is catalytically inactive, when assayed in combination with a 
mutant (R172L) which binds to a specific synthetic site I used in the reaction, but not the 
accessory sites, has been shown to recombine. This indicates that S10L can bind and 
perform the necessary functions of the protein at the accessory sites in the absence of the 
serine residue which is absolutely required for catalytic activity of the protein bound at 
site I. Likewise, the mutant y5 resolvase E128K which is unable to bind to site IE, but is 
catalytically active at site I, when used in conjunction with SI OL recombines efficiently.
It is thought that the mutants complement each other, with S10L binding at the accessory 
sites while E128K performs the catalytic activity required at site I (Grindley, 1993). The 
mutant R2A, which cannot perform the “2-3”’ interaction thought to occur in the 
interwrapped accessory sites, does not complement E128K in recombination assays.
Prior to this project, no mutants of Tn3 resolvase had been isolated.
1.10 The role of sites II and III of res
Various experiments have been carried out with a view to determining the role of sites E 
and III in the recombination reaction. A hybrid site (ges) was created, consisting of a gix 
site placed next to sites II and El of res, with the spacing between the centre of gix and
16
the centre of site II the same as in res. These ges sites were cloned in direct repeat in a 
supercoiled plasmid, meaning that the gix sites were also in direct repeat. Reactions 
carried out with Gin but lacking resolvase resulted in no recombination, but the addition 
of resolvase to the reaction resulted in a recombination event, with the product being a 
(-2) catenane (M. Boocock and C. Koch, personal communication). This indicates that 
the presence of sites II and in  of res can define the topology of the product of Gin- 
mediated recombination. Sites H and ID therefore play a major role in synapsis of wild- 
type res sites.
A second series of experiments, in which site I of res was replaced by a loxP site, and 
resulting in the creation of hybrid “les” sites, yielded similar observations. The loxP site 
is from bacteriophage PI, and is recombined by the Cre recombinase. Substrates with les 
sites incubated with Cre, resulted in free circle resolution products and unknotted 
inversion products typical of this system. The addition of resolvase to the reaction 
resulted in 3 noded inversion products and 4 noded catenane resolution products. Strand 
exchange in the Iojc/Cre system apparently has a left handed sense, resulting in resolution 
products of 4 nodes instead of the 2 noded product resulting from the right handed 
resolvase system. Analysis of these products indicates that sites II and III are regulating 
the system by bringing the lox sites together in a specific geometry and topology (E. 
Kilbride, personal communication).
The accessory sites II and III have been shown to be important for the alignment of the 
crossover site in site I (Bednarz, 1989). The left and right arms of the crossover site (site 
I) differ at 6 of 11 positions: Does resolvase recognise these differences in order to align 
the sites correctly, or is alignment indirect, via alignment of sites II and El? Correct 
alignment of the crossover site was shown not to require sequence asymmetry at the 
crossover site, DNA supercoiling, or the covalent linkage of res sites, but was determined 
by resol vase-mediated interactions of sites E and III of both partners. It was shown that 
deletion of one of the sets of sites E and IE reduced the efficiency of resolution greatly, 
but that substrates with site I in direct or inverted repeat with the complete res were 
resolved equally well. Therefore, deletion of sites II and III results in the failure of 
resolvase to recognise the orientation of the site. In a substrate containing res sites with a 
perfectly symmetrical crossover site, the product was shown to be exclusively the
17
resolution product, a (-2) catenane, indicating that sites II and III are sufficient to 
determine correct alignment. The above experiments strongly support roles for the 
accessory sites in promoting the early stages of synapse formation, in correctly aligning 
the site I’s in activating catalysis at site I, and in defining the topology of recombination.
1.11 Project aims
The aim of this project was to create and isolate mutants of TnJ resolvase, in order to 
further understand the recombination reaction. In order to do this, a vehicle in which the 
mutant resolvases could be created had to be developed. This plasmid had also to be 
compatible with an in vivo screen which exists in the laboratory. Analysis of these 
mutants also demanded the development of a resolvase purification system which was 
reliable and reproducible for a number of mutants.
Previous work has indicated that sites II and III play an important role in the alignment of 
the crossover site. A priority was the isolation of a TnJ resolvase mutant able to catalyse 
recombination between two site I’s, in the absence of the accessory sites, to understand 
more about their role in recombination.
Chapter 2
Materials and methods
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2.1 Bacterial strains
Bacterial strains used are listed below in table 2.1. The majority of the strains used were 
derivatives of Escherichia coli K-12, with the exception of BL21 which is an Escherichia 
coli B derivative.
STRAIN GENOTYPE SOURCE
AB1I57 thr 1, leu6, hisG4, thil, aral4, pro A2, argE3, galK2, 
sup31, xyl 15, mr/1, tsx33, str3l
BL21 E. coli B, F~ 4cm, ompT, hsdS(rQ mb") gal W. Studier
BL21 DE3 hsd, gal, (Xcl ts 857, indl, Sami, ini5, /<acuv5-T7 gene-1) W. Studier
BMH 71-18 
mut S
thi, supE, A(lac-proAB), [mwrS::TnlO}, {F’, / 7roAB, 
/acZAM15, laclQ]
Promega
DH5a F’,cp80d, /acZAM15, A(lacZYA  -argF), U169, deoR, 
recA l, endAl, phoA, h sdR ll (r -^, mk+), supE44, X~, thi- 
1, gyrA96, relAl
GIBCO
DS941 A B1157, but recF143, supE44, lacZAM\5, lacIQ D. J. Sherrattt
EMI DS941, but mutL E. Morrell
JM109 endAl, recAl, gyrA96, thi, hsdR ll (ri<-, mk+), rel A l, 
supE44, X~, A(lac-pro AB), [F’, traD36, pro AB, 
lac7AWH5, lacIQ]
Promega
Table 2.1 Bacterial strains 
2.2 Plasmids
Plasmids used and constructed throughout this work are listed in Table 2.2.
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2.3 Chemicals
Sources of general chemicals are listed in Table 2.3. All solutions were made using 
deionised water.
CHEMICALS SOURCE
General chemicals, Biochemicals, Organic solvents Aldrich/Sigma, BDH, May & Baker
Media Difco, Oxoid
Agarose BRL, FMC
Acrylamide National Diagnostics, Bio-Rad, Aldrich
Radiochemicals ICN Biochemicals
lOx Restriction Enzyme buffers BRL, Boehringer Mannheim, Promega
lOx Ligase buffer Promega
5x Ligase buffer BRL
Table 2.3 Chemicals 
2.4 Media
Escherichia coli was grown in liquid L-Broth and on solid L-Agar. MacConkey 
galactose agar was used in order to screen mutants. 2xYT broth was used for expression 
purposes. Growth of cultures for the preparation of competent cells was in cp broth. 
Details of growth media are listed below.
L-Broth : 10 g bacto-tryptone, 5 g bacto-yeast extract, 5 g NaCl, made up to 1 
litre with deionised water. NaOH used to adjust to pH 7.5.
L-Agar : L- Broth with 15 g/1 Agar.
2xYT Broth : 16 g bacto-tryptone, 10 g bacto-yeast extract, 5 g NaCl, made up 
to 1 litre with deionised water. pH adjusted to 7.0 with NaOH.
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cp Broth : 2% w/v tryptone, 0.5% w/v yeast extract, 20 mM MgSC>4, 10 mM 
NaCl, 5 mM KC1, adjusted to pH 7.5 with KOH.
MacConkey Galactose Agar : (17 g bacto-peptone, 3 g bactoprotease 
peptone, 1.5 g bacto bile salts No.3, 5 g NaCl, 13.5 g bacto agar, 0.03 g neutral 
red, 0.001 g bacto crystal violet) supplied ready made by Difco, 1% D-galactose, 
made up to 1 litre with deionised water.
2.5 Bacterial growth conditions
Bacterial cultures were grown at 37 °C with shaking. Growth on agar plates was at 37 °C 
with the plates inverted. Antibiotics used for selection are listed in Section 2.7. Bacterial 
strains were stored long term by diluting an overnight liquid culture, in a 1:1 mixture with 
40% glycerol, 2% peptone. These stocks were stored at -70 °C.
2.6 Antibiotics
The antibiotics used and their working concentrations in liquid and solid media are listed 
below, Table 2.4.
ANTIBIOTIC STOCK SOLUTION SELECTIVE CONDITIONS
Ampicillin (Ap) 5 mg/ml in H 2 O 50 |ig/ml
Chloramphenicol (Cm) 2.5 mg/ml in ethanol 25 fig/ml
Kanamycin (Km) 5 mg/ml in H 2 O 50 |ig/ml
Tetracycline (Tc) 12.5 mg/ml in 70% ethanol 12.5 fig/ml
Table 2.4 Antibiotics 
2.7 Competent cells
Competent cells were prepared by the two methods detailed below. Highly competent 
cells, DH5a, for the construction of a mutant library were bought in from Gibco BRL.
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2.7.1 RbCl method
TFB 1 : 30 mM KOAc, 100 mM RbCl, 10 mM CaCl2.2H20 , 50 mM
MnCl2.4H20 , 15% glycerol, pH adjusted to 5.8 with AcOH
TFB II : 10 mM MOPS, 75 mM CaCl2.2H20 , 10 mM RbCl, 15% glycerol, pH
adjusted to 6.8 with HC1 or KOH
TFB I & II were filter-sterilised.
4 ml of overnight culture, grown from a single colony in cp broth, was used to inoculate 
200 ml of pre-warmed cp broth and grown to an ODsoo of 0.46-0.6. The cells were 
cooled rapidly in ice and water and pelleted by centrifugation (Beckmann J2-21, 5 000 
rpm, 10 minutes, 4 °C) in a pre-chilled rotor. The pellet was resuspended gently in 40 ml 
of ice-cold TFB I, and the suspension was left on ice for 30 minutes, then spun ( 5 000 
rpm, 10 minutes, 4 °C). The pellet was resuspended in 8 ml of cold TFB II and the 
suspension was left on ice for 15 minutes. Aliquots of 200 p,l were dispensed into pre­
chilled tubes, and frozen rapidly in liquid nitrogen before storing at -70 °C.
2.7.2 CaCl2 method
1 ml of overnight culture was inoculated into 19 ml of fresh L-broth, and grown until the 
OD600 was 0.4-0.5. Cells were spun down, by raising the centrifuge to a speed of 10 K 
and stopping immediately. The pellet was resuspended in 10 ml pre-chilled 50 mM 
CaCl2. Cells were respun as above and resuspended in 1ml of 50 mM CaCl2. Cells 
were then stored on ice where they maintained competence for up to 48 hours.
2.8 Transformation
Competent cells prepared by different methods required slightly different transformation 
procedures. These are detailed below.
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2.8.1 RbCl prepared cells
DNA (0.1 pg) was added to 50 pi of cells thawed on ice. This was mixed gently and 
incubated at 0 °C for 30 minutes. Cells were ‘heat shocked’ by incubation at 37 °C for 5 
minutes, and returned briefly to ice where 5 volumes of 2xYT Broth was added. The 
cells were then allowed to recover by incubation at 37 °C for 90 minutes. Aliquots were 
spread onto selective agar plates, which were then incubated at 37 °C overnight.
2.8.2 CaCl2 prepared cells
DNA (0.1 pg) was added to 200 pi of cells and the samples were mixed gently on ice, 
then left for 15 minutes on ice. The cells were heat shocked at 37 °C for 5 minutes, and 
returned to ice for a further 15 minutes. 1ml of L-Broth was added and the cells were 
expressed at 37 °C for 90 minutes. Aliquots were then spread onto selective plates.
2.8.3 DH5a competent cells
0.1 pg of DNA was added to 50 pi of cells thawed on ice. Cells incubated on ice for 30 
minutes. Cells were heat shocked for 20 seconds at 37 °C and returned to ice for 2 
minutes. 0.95 ml of room temperature 2xYT broth was added and the cells expressed at 
37 °C for 1 hour. Cells were then plated onto selective media and incubated overnight at 
37 °C.
2.9 Preparation of plasmid DNA
2.9.1 Large scale preparation of plasmid DNA
The method used here is adapted from Bimboim and Doly (1979).
Doly I buffer : 50 mM glucose, 25 mM Tris-HCl (pH 8.0), 10 mM EDTA 
Doly II buffer : 200 mM NaOH, 1% SDS, made fresh 
Doly III buffer : 0.6 vol. 5 M KOAc, 0.115 vol. AcOH, 0.285 vol. H2O 
TE buffer : 10 mM Tris-HCl (pH 8.2), 1 mM EDTA
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200 ml of overnight culture was grown, and the cells were pelleted (12 000 g, 5 minutes,
4 °C). The pellet was resuspended in 4 ml of Doly I buffer. After transferring to 50 ml 
tubes and chilling on ice for 5 minutes, 8 ml of Doly Et buffer was added, and the tubes 
were mixed by inverting gently . After 4 minutes on ice, 6 ml of ice-cold Doly EH was 
added and the samples were mixed gently before pelleting by centrifugation (39 200 g, 30 
minutes, 4 °C). The supernatant was collected into tubes containing 12 ml of 
isopropanol and the DNA was precipitated at room temperature for 15 minutes, then 
pelleted by centrifugation (27 200 g, 18 00 rpm, 30 minutes, 20 °C). The pellet was 
washed with 2 ml of 70% ethanol and allowed to dry. 2 ml of TE buffer was added and 
the pellet was resuspended at 37 °C.
5 g of CsCl was dissolved in 3 ml of distilled water and the resulting 4.324 ml aqueous 
CsCl was added to the DNA. 270 pi of 15 mg/ml ethidium bromide was added. The 
mixture was transferred to a Beckmann ultra-centrifuge tube. The tubes were filled with 
liquid paraffin and balanced in pairs to within 0.1 g of each other. Tubes were sealed 
with a heat sealer and placed in a Beckmann Ti70 fixed angle rotor such that the balanced 
pairs directly opposed each other. They were spun at 200 000 g (49 000 rpm for 16 
hours at 15 °C), after which the tubes were removed and observed on a long-wave UV 
source (365 nm). At this point two bands were observed, the lower of which 
corresponded to plasmid DNA, the higher being chromosomal DNA. The plasmid DNA 
was then removed by inserting a needle attached to a 1 ml syringe immediately below the 
band and through the wall of the tube. 0.5 ml of solution containing DNA was then 
drawn into the syringe. Four extractions, with 0.5 ml of n-butanol, were carried out to 
remove the ethidium. The solution was diluted with 3 volumes of water, and the DNA 
was precipitated with 2 volumes (of the diluted solution) of 100% ethanol at 4 °C for 20 
minutes. DNA was pelleted by centrifugation (27 200 g, 30 minutes, 4 °C), the pellet 
was washed with 70% ethanol and dried, then dissolved in TE (500 pi). The DNA 
solution was stored at 4 °C.
2.9.2 Small scale preparation of plasmid DNA
Several methods were used to isolate plasmid DNA on a smaller scale. All used an 
Eppendorf microcentrifuge running at 14 000 rpm for the centrifugation steps.
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a) Alkaline lysis
1.5 ml overnight cultures were grown and pelleted by centrifugation (-30 sec.). The 
pellet was resuspended in 200 pi of Doly 1 + 4 mg/ml lysozyme, and left at room 
temperature for 5 minutes. 400 pi of freshly prepared Doly II was added, and the 
samples were mixed by inverting several times before leaving on ice for 5 minutes. 300 
pi of 7.5 M NH4OAC was then added, and the samples were kept on ice for 10 minutes. 
After a 5 minute spin, the supernatant was removed to a fresh tube, whereupon one 
extraction with 0.5 vol. of phenol was carried out followed by one extraction with 0.5 
vol. of chloroform. DNA was precipitated by adding 0.75 vol. of isopropanol, then 
leaving the mixture at room temperature for 10 minutes. The supernatant was removed, 
and the pellet was washed with 70% ethanol and dried. DNA was redissolved in 50 pi 
of TE, and the solutions were stored at 4 °C
b) Mini CsCl
This method is adapted from Saunders and Burke, 1990. Unless otherwise stated, all 
steps in this procedure follow directly on with no incubations.
1.5 ml of overnight culture was spun down and resuspended in 100 pi of Doly I + 
4mg/ml lysozyme. 200 pi of Doly II was added and the samples were mixed gently by 
inversion. 150 pi of Doly III solution was added and the samples were spun for 5 
minutes. The supernatant was removed (380 pi) and 720 pi of isopropanol was added. 
The mixture was vortexed, spun, and the pellet was washed with 70% ethanol. After 
drying, the pellet was resuspended in 100 pi TE. 100 mg of CsCl was added to the DNA 
and the samples were shaken until it was dissolved. 15 pi of 15 mg/ml ethidium bromide 
was added and the samples were spun for 5 minutes. The supernatant was removed and 
4 isopropanol extractions (100 pi) were carried out to remove the ethidium. The solution 
was diluted with 400 pi of TE, and the DNA was precipitated with 50 pi of 3 M sodium 
acetate and 720 pi isopropanol. The samples were spun for 5 minutes, and the pellet was 
washed with 70% ethanol before resuspending in 20 pi TE.
c) Wizard DNA preparation.
DNA was also prepared using the Wizard DNA purification kit (Wizard Miniprep, DNA 
Purification System, Promega), according to the manufacturer's instructions.
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2.10 Restriction enzyme digestion of DNA
Restriction digests were carried out in the suppliers’ recommended buffer with an excess 
of enzyme, between 2-fold and 10-fold, to ensure complete cleavage of the DNA. The 
digest was maintained at 37 °C > 1 hour. On completion, the addition of 0.25 vol. of 
SDS loading buffer, (Section 2.23), or heating to 70 °C for 5 minutes, or one phenol 
extraction (Section 2.12) was carried out to terminate the digest.
Partial restriction digests were carried out using diluted stock enzymes in conjunction 
with a time course of incubation. Visualising the products on an ethidium bromide- 
stained agarose gel indicated the conditions required for the desired level of DNA 
cleavage. DNA was then purified from the gel (Section 2.20).
2.11 Phenol extraction of DNA
The removal of unwanted proteins by phenol extraction was carried out by the addition of 
one volume of phenol (containing 0.1% 8-hydroxy quinoline and equilibrated with 0.5 M 
Tris-HCl pH 8.0). The mixture was vortexed and subsequently centrifuged in an 
Eppendorf microcentrifuge (15 000 rpm, 3 minutes). The aqueous layer containing the 
DNA was removed for further re-extraction if necessary. Residual phenol was removed 
by repeating the extraction with chloroform.
2.12 Ethanol precipitation of DNA
The salt concentration of the DNA solution was adjusted to 0.3 M NaOAc, and 2 volumes 
of 100% ethanol was added. The sample was mixed well and kept at -20 °C > 15 
minutes. The DNA was pelleted by centrifugation in an Eppendorf microcentrifuge (5 
000 rpm, 4 °C, 30 minutes). The pellet was washed in 70% ethanol and briefly respun. 
After removal of the ethanol, the DNA was dried before resuspension in TE buffer.
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2.13 Filling in DNA ends
In order to blunt 3’ recessed ends before cloning a DNA restriction fragment, dATP, 
dCTP, dGTP and dTTP were added to restriction enzyme-digested DNA to a final 
concentration of 125 pM, along with 1 unit of the Klenow fragment of DNA polymerase 
I in 20 |il of BRL REact 2 buffer (50 mM Tris-HCl (pH 8.0), 50 mM NaCl, 10 mM 
MgCl2). The mixture was incubated at 37 °C for 30 minutes, and the reaction was then 
stopped by heating for 5 minutes at 70 °C. The DNA was then recovered by ethanol 
precipitation or gel purification.
2.14 3 ’ End labelling of DNA
DNA was prepared by restriction. 10 pCi of the appropriate [a-32P] dNTP was added to 
the DNA (-1.5 pg), with 1/10 vol. of a mix of the remaining 3 dNTP’s (100 pM each), 1 
unit of Klenow and dH20 to the appropriate volume. The mixture was incubated at room 
temperature for 15-20 minutes. 1 pi of a solution containing containing all 4 dNTP’s at 1 
mM each was added, and the mixture was left at room temperature for 5 minutes. This 
was followed by 1 phenol and 1 chloroform extraction, and the DNA was ethanol- 
precipitated. The labelled DNA was then redissolved in TE buffer.
2.15 Ligations
Ligations were carried out with 1-2 pg of vector DNA in a volume of 10 p i  They were 
carried out between restriction enzyme-digested plasmid DNA fragments, where the 
molar ratio of the vector to insert was 1:2, or in cases where double stranded 
oligonucleotides were ligated into a vector fragment, the ratio of vector to insert was 1:1. 
The buffer used was lxBRL ligation buffer (50 mM Tris-HCl (pH 7.6), 10 mM MgCl2,
1 mM DTT, 5% (w/v) polyethylene glycol-8 000) or lxPromega ligation buffer (30 mM 
Tris-HCl (pH 7.8), 10 mM MgCl2, 10 mM DTT, 0.5 mM ATP), with 1 unit of T4 DNA 
ligase (BRL). The mixture was incubated overnight at room temperature, and 
subsequently used to transform competent cells.
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2.16 DNase I nicking of DNA
DNA (20-100 jig) in C8 buffer (50 mM Tris-HCl (pH 8.2), 10 mM MgCl2, 0.1 mM 
EDTA) with 300 jLig/ml ethidium bromide and 1.6 Jig/ml DNase I was incubated at 37 °C 
for 1 hour. DNase I was then removed by extraction with phenol 3 times followed by 1 
chloroform extraction. The nicked DNA was ethanol-precipitated and redissolved in TE 
buffer.
2.17 Sequencing of double stranded plasmid DNA
The method used and all buffers were as described in the Sequenase T7 DNA polymerase 
technical manual (USB, 1990). These were based on the method of Sanger et al., 1977.
However, the plasmid template was prepared by an alternative method. 3 jug of DNA 
was incubated in 200 mM NaOH at 37 °C for 15 minutes. The sequencing primer (-10 
pmol) was added, and the sample was mixed vigorously. The DNA was precipitated by 
adding 120 jil of chilled ethanol and 12.75 jllI 5 M ammonium acetate (pH 7.5), and kept 
at -20 °C for 30 minutes. Pelleting was carried out by centrifugation (12 000 rpm, 30 
minutes, 4 °C). The pellet was washed in 70% ethanol, repelleted and dried before 
resuspension in deionised H20 . The template was then sequenced as described in the 
Sequenase protocol.
2.18 Oligonucleotides
Oligonucleotides used were synthesised on Applied Biosystems 391 or 392 
oligonucleotide synthesiser or using standard cyanoethyl phosphoramidite chemistry. All 
reagents were supplied by Cruachem Ltd.
Randomly mutated oligonucleotides for the purposes of mutagenesis (see Chapter 4) were 
made by contaminating each of the four phosphoramidite reagents with 1 % of each of the 
other three, resulting in a theoretical rate of mutagenesis of 2.5 base changes per 100 
nucleotides.
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Oligonucleotides used for mutagenic purposes are detailed where appropriate in the text, 
oligonucleotides used for sequencing purposes are detailed in Table 2.5.
OLIGONUCLEOTIDE SEQUENCE
P I C GAC T CAC TATAGGGGC
P 2 GGCTGGATTTGTGAGG
P3 TTATTATCATGACATTAACC
P4 GAGTTTGATGCTCAGGGTGTAG
P5 C GAC TCAC TATAGGGGA
Table 2.5 Details of sequencing primers
Primer PI is outside the N-terminal end of the resolvase open reading frame in the p- 
SELECT-1 vector, priming extension of the top strand, while P2 is used to sequence the 
reverse strand from the C-terminal end of the open reading frame, again in p-SELECT-1. 
The primer P3, sits in the resolvase open reading frame, on the 5' strand. P4, also in the 
open reading frame of resolvase sits on the 5' strand and lies upstream of the Clal 
restriction site. This primer was used in the sequencing the mutants created during 
random mutagenesis. P5 was used to sequence the expression plasmids derived from 
pET plasmids; it is from pETl 1 T-7 promoter region.
After synthesis, 1 ml of 30% aqueous ammonia was added to the glass support and the 
mixture was left at room temperature for 1-2 hours. The glass support was pelleted by 
centrifugation, and the supernatant was removed to a Nunc tube. A further 1 ml of 30% 
aqueous ammonia was added to the Nunc tube, and the cap was screwed on firmly before 
incubating in a 55 °C oven overnight. After cooling on ice, ammonium acetate was added 
to 0.5 M, and the oligonucleotide was precipitated by the addition of 2 volumes of 
ethanol. The oligonucleotide was then purified on a denaturing PAGE-Gel (see Section 
2 .21 ).
2.19 5 ’ Phosphorylation of oligonucleotides
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Phosphorylation of 100 pmol of oligonucleotide was carried out in lx T4 kinase buffer 
(50 mM Tris-HCl (pH 7.5), 10 mM MgCl2, 5 mM DTT, 0.1 mM spermidine, 0.1 mM 
EDTA) with 10 mM ATP. T4 kinase (5 units) was added and the reaction was kept at 37 
°C for 30 minutes. The reaction was halted by heating at 70 °C for 10 minutes.
2.20 Annealing oligonucleotides
The procedure for annealing oligonucleotides to single stranded DNA can be found in the 
p-SELECT-1 manual (Promega). This procedure was also used to anneal two 
complementary oligonucleotide strands. Roughly equal amounts of purified 
complementary oligonucleotides (1-10 pmol) were mixed in TE buffer and heated at 70 
°C for 5 minutes. The oligonucleotides were then cooled to room temperature over a 
period of 20 minutes. Oligonucleotides were now annealed and could be stored at -20 
°C.
2.21 Purification of synthetic oligonucleotides
Oligonucleotides were purified in the following manner. 400 |il of the solution of crude 
oligonucleotide in 30% ammonia (Section 2.3) was precipitated by adding ammonium 
acetate to a final concentration of 0.5 M, followed by 2 volumes of ethanol. The mixture 
was left at -20 °C for 30 minutes. The oligonucleotide was pelleted by spinning in an 
Eppendorf microcentrifuge (15 K, 30 minutes, 4 °C). The supernatant was removed, and 
the pellet was redissolved in 20 |il of TE. A further 20 |il of Formamide loading buffer 
(Section 2.23) was added, and the samples were ran on a denaturing polyacrylamide gel 
(Section 2.22). The DNA was then visualised using ‘Stains all’ (l-ethyl-2-[3-(l- 
ethylnaphtho[ 1,2-d]thiazolin-2-ylidene)-2methylpropenyl) naphtho[ 1,2-d]thiazolium 
bromide; supplied by Aldrich). The gel was immersed in 70 ml of deionised H2O + 20 
ml isopropanol, and 10 ml of 0.1% (w/v) solution of ‘Stains all* in formamide was 
added. The dish was gently shaken until DNA was observed. The full length 
oligonucleotide, usually the slowest and most abundant product on the gel, was removed 
using a scalpel blade, and the gel slice was crushed in 1 ml of TE buffer in a Nunc tube. 
This was placed on a rotating wheel mixer at 37 °C for 16 hours. The acrylamide was 
then removed from the TE/oligonucleotide by spinning through a 0.45 |im cellulose
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acetate filter (Spin-x, supplied by Costar). The oligonucleotide was ethanol-precipitated, 
and spun, and the pellet was washed in 70% ethanol before redissolving in TE buffer.
2.22 Electrophoresis
2.22.1 Agarose gel electrophoresis
lxTAE buffer : 40 mM Tris-acetate (pH 8.2), 20 mM sodium acetate, 1 mM 
Na2EDTA
Gels (0.8%, 1.0%, or 1.2% w/v agarose) were prepared by dissolving the appropriate 
amounts of agarose powder in lxTAE buffer by heating in a microwave oven. The 
solution was allowed to cool to 60 °C and poured into a gel former with the appropriate 
comb, then left to set at room temperature. When pouring gels made of Low Melting 
Point agarose (Seaplaque) the gel was allowed to set at 4 °C to ensure the formation of the 
wells. Two sizes of gels were in general used; ‘Large gels’ required 250 ml of buffer to 
form the gel and 3.2 1 of buffer to fill the gel tank. Gels were run at 40 V for 16 hours, 
or 100-150 V for shorter periods of time. ‘Mini gels’ used 40 ml of buffer + agarose to 
form the gel and 400 ml in the gel tank to run the gel. These gels were electrophoresed at 
80-100 V for the required period of time.
2.22.2 Acrylam ide gel electrophoresis
The various polyacrylamide gels used were all basically set up in the same manner. 0.75 
mm spacers were inserted between glass plates along with a length of rubber tubing in 
order to form a seal. The plates were clamped together and the gel mixture was poured 
between them. A comb was inserted to form the wells, and this was also clamped in 
place. The acrylamide was allowed to polymerise for at least 1 hour before the tubing and 
comb were removed, and the gel was placed in the gel kit. The required volume of buffer 
was added to the tank reservoirs, and the gel was run at a constant voltage for the 
required time.
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a) Non-Denaturing Electrophoresis
lOxTBE buffer : 89 mM Tris-base, 89 mM boric acid, 0.2 mM Na2EDTA (the
resulting pH is 8.3).
Standard polyacrylamide gels were used in the analysis of restriction digests and for the 
purification of small double stranded DNA fragments. For a 30 ml X% polyacrylamide 
gel, X ml 30% acrylamide : 0.8% bisacrylamide (w/v), 3 ml 10 x TBE buffer, (27-X) ml 
H2O, 360 jllI  10% ammonium persulphate (w/v) (APS) and 18 pi TMED (N, N, N \  N’- 
tetramethylethylenediamine) were mixed, then poured as described above. Reservoirs 
were filled with 1 x TBE buffer, and the gel was run at a constant voltage of 200 V at 
room temperature for 3-4 hours. Ethidium bromide was used to stain the gel.
A second non-denaturing PAGE method was used for resolvase band-shift assays. A 6% 
gel was prepared with 6 ml 30% acrylamide : 0.8% bisacrylamide (w/v), 3 ml 500 mM 
Tris-glycine (pH 9.4), 15 pi 200 mM EDTA, 21 ml H2O, 360 pi 10% APS (w/v) and 18 
pi TMED. The running buffer was 50 mM Tris-glycine (pH 9.4), and 0.1 mM EDTA in 
deionised water. The gel was poured as previously described, but care was taken to keep 
all equipment detergent-free. Electrophoresis was carried out at 4 °C at a constant voltage 
of 200 V.
b) Denaturing polyacrylamide gels
Denaturing gels were used for plasmid sequencing and for purification of synthetic 
oligonucleotides. For a standard 6% polyacrylamide sequencing gel, 80 ml of Sequagel- 
6 was mixed with 20 ml of Sequagel Complete (supplied by Protogel), then 600 pi of 
10% APS (w/v) was added to the mixture. The mixture was poured between the glass 
plates, a shark’s tooth comb was inserted (flat edge inwards) and the gel was left to 
polymerise at room temperature for 20 minutes. 1 volume of formamide loading buffer 
was added to samples (see Section 2.23), which were then heated to 80 °C for 5 minutes 
prior to loading. Two sequencing gel kits were used; an IBI Base Runner ki t , which 
was pre-run at 45 W for 1 hour and run at 45 W for 2-3 hours, and a BRL model S2, 
which was pre-run at 100 W for 45 minutes before running for 1.5-3 hours at 60 W. The 
gel was dried under vacuum and autoradiographed as described in Section 2.31.
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Purification of oligonucleotides was also carried out on denaturing gels, in a smaller gel 
kit, but due to variations in length a variety of gel percentages was used. For 100 ml of a 
10% polyacrylamide/7 M urea gel, 46 g Urea, 15 ml of 40% (w/v) acrylamide (19:1  
ratio of acrylamide to bisacrylamide), 10 ml of 10 x TBE, 666 fil of 10% (w/v) APS and 
40 jil of TMED was made up to 100 ml with deionised water. This was poured between 
glass plates, and a comb was inserted to form the wells. The gel was polymerised at 
room temperature for 1 hour before samples, to which 1 volume of formamide loading 
buffer had been added, were loaded. The gel was pre-run at 15 W and mn, also at 15 W, 
for 2-4 hours.
Protein denaturing gels were also run; these were of the type described in Laemmli, 1970. 
They were run in a Biorad "Miniprotean" gel kit. Gels were made and run according to 
the manufacturers instructions.
2.23 Analysis by single colony gel
Single colony gel lysis buffer : 2.5% Ficoll, 1.25% SDS, 0.01% 
Bromophenol Blue in lxTAE buffer.
This technique was used to confirm the presence and size of plasmids in E. co li . 
Transformants were patched onto fresh selective agar plates and grown at 37 °C for > 8 
hours. Bacteria were scraped from the patches with a toothpick, then twiddled into 
Single colony gel lysis buffer and the samples were incubated at room temperature for 15 
minutes, then spun in an Eppendorf microcentrifuge ( 15 K, 30 minutes, 4 °C). 
Approximately 30 jil was loaded onto a horizontal 1.2% agarose gel, described in Section 
2 .20 .
2.24 Purification of DNA from low melting point agarose
The low melting point agarose used was Seaplaque GTG (supplied by FMC Inc.). The 
gels were run as described in Section 2.20 and stained with ethidium as detailed in 
Section 2.28. After visualising the DNA on a long wavelength transilluminator (365 
nm), the DNA was removed by cutting out a gel chip with a scalpel blade. The chip was
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melted at 65 °C for 5 minutes and 100 |xl of TE buffer was added to reduce the agarose 
concentration, which makes it easier to extract and makes the volume more manageable. 
The agarose was removed by three phenol extractions, followed by one chloroform 
extraction. The DNA was ethanol precipitated, washed with 70% ethanol and redissolved 
in the required volume of TE.
2.25 Loading buffers
The following loading buffers were used throughout this thesis.
SDS-Loading buffer : 50% glycerol, 1% SDS, 0.01% bromophenol blue
Formamide loading buffer : 80% deionised formamide, 10 mM EDTA (pH 
8.0), 1 mg/ml xylene cyanol, 1 mg/ml bromophenol blue
Laemmli loading buffer : 50 mM Tris-HCl (pH 6.8), 1% SDS, 10% (w/v) 
glycerol. 0.01% bromophenol blue.
2.26 Size markers
The BRL 1 kb ladder was used as a marker on agarose and acrylamide gels to help 
determine the size of DNA run on these gels.
Purified resolvase was used as a marker on protein gels.
2.27 UV spectrophotometry
Concentrations of DNA were measured by diluting the DNA, then measuring the 
absorbance at 260 nm in a UV/visible spectrophotometer (Shimadzu).
The concentration of double stranded DNA was calculated by approximation that a 
solution with an absorbance of 1 at 260 nm in a 1 cm cell contains 50 |ig/ml of double 
stranded DNA.
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Synthetic oligonucleotide concentration was estimated using the relationship ;
A = £ c 1
A = Absorbance at 260 nm
e = Extinction coefficient, 10 0001 mol"'em*1 per nucleotide 
c = Molar concentration 
1 = Path length of the cell (cm)
2.28 Staining of gels
2.28.1 Visualising DNA
DNA was visualised in agarose and acrylamide gels by staining with an ethidium bromide 
solution (0.6 p.g/ml) in 1 x TAE buffer. Staining was carried out for 30-60 minutes; the 
gel was then rinsed and soaked in water for 60 minutes to remove any background 
staining which had occurred. DNA was visualised on a 254 nm UV short wavelength 
transilluminator.
2.28.2 Visualising proteins
After electrophoresis on a Laemmli poyacrylamide gel (Section 2.20) proteins were 
visualised using the following reagents;
Coomassie Stain : 1% Coomassie Blue, 50% MeOH, 10% AcOH 
Coomassie Destain : 10% MeOH, 10% AcOH
Proteins electrophoresed on an SDS polyacrylamide gel were stained with Coomassie 
stain for 30 minutes, then destained as required. Bands were then observed by 
illumination on a light box.
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2.29 Photography, autoradiography & phosphorimagery
Agarose and polyacrylamide gels were photographed using a Polaroid camera and 
Polaroid 667 film, or a Pentax SLR camera loaded with Ilford HP5 35 mm film. Ilford 
film was processed using Ilford Microphen developer (undiluted, 11 minutes at 20 °C), 
followed by fixing with Amfix (diluted 1 + 3, 5 minutes at 20 °C).
For autoradiography purposes, the gel was dried under vacuum in a Bio-Rad slab gel 
dryer, and exposed overnight to a sheet of Fuji RX100 film. This was developed in an 
X-OMAT automated processor (Kodak).
Phosphorimaging was carried out on gels dried as above, then exposed overnight to 
phosphor screens. The screens were processed in a Fuji BAS-1000 phosphor-imaging 
system.
2.30 M utagenesis
2.30.1 p-SELECT-1 based directed mutagenesis
The method used was as described in the ‘Altered Sites’ technical manual (Promega), but 
the mutagenesis template was prepared by denaturation of double stranded plasmid DNA 
(Section 2.6) which had previously been nicked by DNase I (Section 2.19).
2.30.2 Random mutagenesis
The procedure for random mutagenesis using mutated synthetic oligonucleotides is 
detailed fully in Chapter 4.
2.31 Screening of resolvase mutants
The screening of mutated Tn3 resolvase was as described in Blake, 1993 and is described 
fully in Chapter 4.
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2.32 Expression and purification of Tn3 resolvase and derived 
mutants
The expression system used to overproduce Tn3 resolvase and its mutants is described in 
Chapter 5. The purification protocol developed is detailed in Chapter 5.
2.33 In vitro recombination by Tn3 resolvase
Site-specific recombination reactions involving TnJ resolvase and mutants thereof were 
carried out in several reaction buffers, detailed below.
C9.4 buffer : 50 mM Tris-HCl (pH 9.4), 10 mM MgCl2, O.lmM EDTA 
C8 buffer: 50 mM Tris-HCl (pH 8.2), 10 mM MgCl2, 0.1 mM EDTA 
M15M8 buffer: 50 mM Tris-HCl (pH 8.2), 5 mM MgCl2, 5 mM spermidine, 
0.05 mM EDTA, 20% v/v glycerol.
A 20  |ll1 reaction in the appropriate buffer contained 0.4  p g  of plasmid DNA with 0.05  
vol. (1 pi) of diluted resolvase. Incubation at 37 °C was carried out, the duration being 
dependent on the protein and buffer involved. The reaction was then stopped by heating 
at 70 °C for 5 minutes. In general, 60 pi reactions were carried out and split into three 
aliquots of 20 pi after incubation. Recombination products were then analysed by 
agarose gel electrophoresis of :-
i) Untreated samples
ii) Samples digested with restriction enzymes
iii) Samples nicked with DNase I (Section 2.19)
Prior to loading, 5 pi of SDS loading buffer was added to all 20 pi samples.
2.34 Band shift analysis
This was carried out as described in Bednarz, 1989 and Blake, 1993.
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50 (ig/ml of non-specific carrier DNA (supercoiled pUC71K) was combined with the 
appropriate amount of end-labelled res DNA (-200-300 cps) in Binding buffer (10 mM 
Tris-glycine pH 9.4, 0.1 mM EDTA, 10% glycerol). The mix was divided into 10 |xl 
aliquots and 0.4 |il of a resolvase dilution was added. The samples were incubated at 37 
°C for 15 minutes, then placed on ice until loading on a non-denaturing polyacrylamide 
gel (Section 2.20). Electrophoresis was carried out at 200 V for 3-4 hours at 4 °C.
Chapter 3
Construction of a resolvase mutant selection system
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Construction of a resolvase mutant selection system
3.1 Introduction
In order to investigate the role of sites II and IE of Tn3 resolvase in the formation of the 
synapse, it was decided to search for mutants which require only the presence of two site 
Fs for synapsis and recombination. The positions and types of these mutants, and 
analysis of the products of such a recombination event might help determine the role of 
sites E and El as well as the actual mechanism of the reaction (e.g. by facilitating 
crystallisation of an active form of the protein).
The analogy of sites E/IE of res with the enhancer element required by DNA invertases 
was noted above (see Introduction). Mutants of the DNA invertase, Gin, have been 
isolated which can carry out inversion in vitro without the presence of the accessory 
factor, Fis (Klippel et al., 1988a, 1988b; Klippel et al., 1993; Merker et al., 1993). Some 
mutants of Cin have also been reported to carry out recombination in the absence of the 
enhancer element (Haffter and Bickle, 1988). Hin mutants have also been isolated which 
are independent of Fis activation in vitro (Yuan et al., 1991; Haykinson et al., 1996).
Comparison of the sequences of the resolvases and Gin has shown that the positions of 
the Fis-independent Gin mutations are in the region which has been shown in y8 
resolvase to be involved in protein/protein contacts of the 1-2 dimer (Hughes et al.,
1993). In the co-crystal structure of y8 resolvase (Yang and Steitz, 1995) this region is 
part of the E-helix, a long a-helical segment extending from amino acid residue M l03 to 
G137. Analysis of the Gin mutants supports a model for Gin inversion which is related 
to models for resolution by Tni resolvase, whereby Fis bound to the enhancer helps in 
the formation of a synapse of defined topology, allowing the gix sites at which Gin is 
bound to recombine. This model equates site I of res with the gix sites, and sites E and 
El (the accessory sites) with the enhancer.
Previous attempts to create Tn3 resolvase site II/IE independent mutants using chemical 
mutagenesis or mutated oligonucleotides were unsuccessful (Blake, 1993). Since the Gin 
and Hin mutants found to be independent of Fis were present in the E-helix of the
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protein, this seemed the most likely place to target the search for Tni mutants. It was 
therefore decided to adopt the strategy of specifically mutagenising the sequence 
corresponding to the region of the E-helix at a high level.
To search for mutants of Tn3 resolvase which could promote recombination of a substrate 
containing only two copies of site I, or one complete res site and one isolated site I, it was 
necessary to construct an appropriate expression vector in which the mutants would be 
created. The vector would be compatible with the in vivo screening system which already 
existed in the lab (Blake, 1993).
3.2 Screening of Tn3 resolvase mutants
The in vivo selection system existing in the lab was based on substrates containing the 
galK  gene, and was fully described in Blake, 1993.
This system was adapted from resolution substrates such as pMA21 (Bednarz et al., 
1990). Resolution of pMA21 results in two smaller circular products, one of which 
contains the ampicillin resistance gene (Bla) and the pBR322 origin of replication. Only 
this product therefore has the ability to be maintained in vivo, while the other product 
(carrying the tetracycline resistance gene of pBR322) is lost (Figure 3.1). Thus colonies 
containing only resolved products could be identified by replica plating and identification 
of ApITcs colonies against a background of colonies containing ApITcr unresolved 
pMA21. By cloning a galK cassette (MeKenney et al., 1981) into the tetracycline 
resistance gene region of pMA21, the assay was made more direct. Cloning disrupted the 
Tcr gene, and allowed an assay for resolution whereby Apr galK  isolates (containing only 
the resolved plasmid) could be identified when using Aps galK  cells wild type for the 
other genes involved in the uptake and metabolism of galactose (e.g. DS941; Miller,
1972). A further refinement was to increase the sensitivity of the assay by reducing the 
copy number of the substrate plasmid, by replacing the pBR322 origin of replication with 
that of pSClOl (Blake, 1993). The original system used by Blake (1993) was 
considered to be non-optimal because the test plasmids had the high copy number 
pBR322 origin of replication. The high copy number means that very efficient resolution 
by a mutant is required to delete all galK genes from individual cells, thus increasing the
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difficulty of isolation of mutants. Also, for some earlier strategies for making mutants it 
was desirable to use the commercially available plasmid p-SELECT-1, which has the 
pBR322 origin and Apr resistance marker. Four new plasmids, pDB34, pDB35, pDB36 
and pDB37, were therefore constructed (Blake, 1993) with Kmr marker and the low 
copy number pSClOl origin of replication. However, they had not been used in 
resolution assays prior to this work. The plasmids are illustrated in Figure 3.2.
MacConkey galactose plates were used to screen the colonies; on these plates galKr 
colonies are pale yellow/white, while galK+ colonies are red. MacConkey agar contains 
2-methyl-3-amino-6-dimethyl-aminophenazine (Neutral red). This indicator is red at pH 
< 6.8 and yellow at pH > 8.0. Bacterial fermentation of reducing sugars (e.g. galactose) 
lowers the pH of the medium, giving rise to colonies which are red/pink. If galactose is 
the only sugar present, galK~ cells are forced to metabolise amino acids in the media.
This produces ammonia which causes an increase in pH, resulting in yellow/white 
colonies.
Using this system we were able to screen for mutants with various properties. Not only 
did we possess a screen for a mutant able to resolve a plasmid containing two site I’s, but 
screens using pDB36 and pDB37 (plasmids containing site I v res) were potentially 
useful since one round of mutagenesis might not produce a resolvase active on a site I v 
site I plasmid. A mutant resolving pDB36 or pDB37 might provide a stepping stone to 
eventually isolating such a mutant.
3.3. Development of a mutagenesis plasmid
Construction of a plasmid for the mutagenesis involved the modification of a p-SELECT- 
1 based plasmid. A suitable plasmid should express a low level of resolvase (to ensure 
compatibility with the in vivo screen), and should contain two unique restriction sites 
positioned approximately at the ends of the sequence corresponding to the E-helix of 
resolvase, allowing this region to be removed by restriction digest for the insertion of 
sequence containing mutations. The open reading frame of resolvase already contains a 
BamHl site which corresponds to a position near the C-terminal end of the E-helix. To 
make use of this restriction site, other pre-existing BamHl sites in the p-SELECT-1
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Figure 3.2 Diagram of resolvase screening plasmids
The four resolution plasmids used to screen for resolvase 
mutants. The origin of replication and rep A gene for 
replication initiator protein are from pSClOl. galK  is 
transcribed from PargR, the promoter of the E. coli argR 
gene.
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derived plasmid had to be removed. No restriction site existed at the other end of the E- 
helix, approximately 80 base pairs upstream, and since the introduction of a new 
restriction site must not alter the amino acid sequence, its possible type and position were 
limited. It was found by inspection of the sequence that a Clal site could be introduced in 
the required region. This again would require the removal of the existing Clal site just 
outside the tetracycline gene in p-SELECT-1.
3.3.1 Site-directed mutagenesis of pSELECT-1
The open reading frame of resolvase was cloned from pMA6111 (Blake, 1993) into p- 
SELECT-1. pMA6111 was digested completely with Sspl and this was followed by a 
partial BamHl digest. The desired tnpR fragment (742 bp) was gel-purified. A 
SaWSmal digest was carried out on p-SELECT-1, and the 5665 bp fragment was also 
gel-purified. Both fragments were treated with Klenow DNA polymerase to fill in the 
ends prior to ligation. The ligation mix was transformed into DS941 competent cells, and 
transformants were investigated to determine the number of BamHl sites present, by 
restriction digest of DNA prepared by alkaline lysis. Filling in the ends of the insert 
removed the unwanted BamHl site outside the open reading frame. This plasmid, pATl, 
is illustrated in Figure 3.3.
After confirmation that only one BamHl site existed in the plasmid, it was necessary to 
remove the Clal site near the tetracycline gene. Initially this was attempted by restriction 
digestion with Clal followed by filling in with Klenow enzyme and religation. However, 
after transformation and selection with tetracycline, the only transformants observed 
contained a Clal site. It was observed that the position of the Clal site is close to the 
promoter of the tetracycline gene on the plasmid. “Filling in” the ends alters the spacing 
between the -10 and -35 boxes by 2 bp, presumably resulting in successfully filled in 
clones being tetracycline-sensitive and selected against (Pruss and Drlica, 1986). 
Tetracycline resistance is the only antibiotic marker present in the plasmid.
It was decided to overcome this problem by an alternative approach. At the same time as 
annealing the oligonucleotide to create the new Clal site in the open reading frame, and 
the ampicillin repair oligonucleotide as a means of selection, a third oligonucleotide would
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Figure 3.3 Illustration of pATl and pAT2
Steps involved in constructing pAT2 involved the repair of the Ampicillin gene 
and the removal of the Clal site in the Tetracycline gene.
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be annealed to remove the existing Clal site, by changing one base pair, without altering 
the length of the promoter sequence. Site-directed mutagenesis was carried out as 
described in the p-SELECT manual (Promega, 1991) on single stranded DNA of pATl 
(Section 2.30.1). The oligonucleotides used for this are detailed in Figure 3.4.
After multiple attempts, this approach proved unsuccessful. The majority of the clones 
isolated, though having the ampicillin resistance gene and a Clal restriction site, were 
shown to be approximately 2.5 kb, probably indicating that a deletion had taken place. 
Further attempts yielded similar results.
By cloning half of the open reading frame stretching between the EcoRl site and the 
BamHl site into p-SELECT, we effectively removed a segment of DNA containing a 
direct repeat. The construct retained the region of the gene required for mutagenesis. 
However mutagenesis on this construct, pA Tl.l was also not successful. Similar 
difficulties in site-directed mutagenesis of mpR have been encountered before, both in 
this lab and in Nigel Grindley’s group (M. Boocock, personal communication).
From the many clones isolated, one was found to have removed the existing Clal site, 
though it did not contain the desired new Clal site. This clone was the correct size, as 
determined by Single Colony gel analysis, and conferred resistance to both ampicillin and 
tetracycline. This plasmid, pAT2, is shown in Figure 3.3.
It was decided to discontinue this approach to introduce the new Clal site in the TnpR, 
but the plasmid which had been created, pAT2, proved useful in the alternative approach 
described in Section 3.3.2.
3.3.2 The creation of a TnpR cassette
Instead of introducing the required restriction sites by site-directed mutagenesis, it was 
decided to create synthetically two thirds of the resolvase open reading frame by 
annealing and cloning a series of complementary oligonucleotides, which would maintain 
the wild type amino acid sequence of resolvase, but which would contain altered 
nucleotides introducing restriction sites at various points. These oligonucleotides would
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utilise the Mlul site near the beginning of the open reading frame present in pSAl 101 (S. 
Rowland, unpublished results; Figure 3.5), and continue to the BamHl site, 341 bp 
downstream.
In order to carry this out, the resolvase reading frame containing the Mlul site, from 
pSAl 101, had to be cloned into the p-SELECT-1 based vector, pAT2. This was 
followed by the cloning and piecing together of the required series of oligonucleotides.
pSAl 101 was digested with Xbal, and the ends were filled in with Klenow enzyme. The 
700 bp fragment was gel purified on a mini Seaplaque agarose gel. pAT2 was digested 
with EcoRl and HindHL, the ends were filled in with Klenow, and the large 5.639 kb 
fragment was gel-purified. The two fragments were ligated, and the ligation mixture was 
used to transform competent DS941 cells. Ligation of these blunt ended fragments 
recreated both Xbal sites and the EcoRl site, but removed the HindlU site originally in the 
vector. This was useful since a unique HindQl site could then be incorporated into the 
cassette. Since a blunt ended ligation was carried out, the insert had the potential to be in 
either orientation. After the isolation of possible clones, the orientation of the insert was 
confirmed by analysis of a restriction digest (EcoKV to Mlul) .  Two clones were isolated 
which had incorporated the fragment, in different orientations. These clones (pAT3a, 
pAT3b; Figure 3.6) were checked for resolvase expression in vivo using the galK system 
(Section 3.2). Both were shown to express sufficient resolvase to resolve the test 
plasmid, pDB34 (bearing the galK gene) and it was decided to use the clone, pAT3a, in 
which the reading frame had inserted in the same direction as the T7 promoter (since this 
was similar to previously constructed plasmids, e.g. pDB6020; Blake 1993). However, 
it is still uncertain as to whether expression is from the T7 promoter (by E. coli RNA 
polymerase) or an “anonymous” promoter elsewhere.
3.3.3 Oligonucleotide cloning and assembly
In designing the oligonucleotides which would comprise the cassette, it was important to 
make them of a length which was relatively easy to synthesise and manipulate, but this 
was dependent on the possible positions at which restriction sites could be introduced 
without changing the encoded amino acid sequence. Figure 3.7 shows a schematic
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Illustration of the expression plasmid pS A 1101. Full details of its 
construction can be found in chapter 5.
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This shows the development of the required plasmid for mutagenesis, with the 
introduction of the new restriction sites in pAT4. pAT3 was created by 
cloning the open reading frame of Tn3 resolvase from pSAl 101 into pAT2. 
pAT4 was then constructed by the insertion of oligonucleotides (Figure3.7) 
into pAT3. The Pstl site at position 387 is not unique (see text).
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diagram of the positioning of the chosen new restriction sites. The eight oligonucleotides 
required were between 76 and 90 bp in length, and their sequences are shown in full in 
Figure 3.8. In addition to the introduction of unique restriction sites ~ 80 bp apart, a Pstl 
site was introduced near the BamHI site. This site exists in the open reading frame of 78 
resol vase, and its incorporation into the TnJ open reading frame allows for the future 
production of yS/Tni hybrid mutant proteins, which may yield important information.
The oligonucleotides were synthesised by standard methods (Section 2.18) and purified 
on a 10% polyacrylamide gel (Section 2.22.2b). The oligonucleotides were then 
annealed (Section 2.20) in the following sets; 1+5, 2+3+6+7, and 4+8. After annealing 
they were cloned into pMTL23, a standard cloning vector used in this laboratory 
(Chambers et a l,  1988) to create three intermediate plasmids, pATl/5, pAT23/67 and 
pAT4/8 (Figure 3.9). The inserts were sequenced to ensure that they carried no mutated 
bases. Once this had been confirmed, the cloned oligonucleotides were put together in 
the following manner. The fragment Mlul to HindTH (1+5) was removed by restriction 
digest from pATl/5 and purified. This fragment was then cloned into pAT23/67, 
containing the oligonucleotides creating the open reading frame from the HindTH to the 
Clal site (2+3+6+7), which had been digested with Mlul/HindHl and the large fragment 
gel-purified. Confirmation that the six oligonucleotides were now present was obtained 
by restriction digest analysis, and this plasmid was named pAT123. Unfortunately, due 
to the positioning of the Clal and BamHI restriction sites in pMTL23, the remaining 
double stranded oligonucleotide stretching between these sites (4+8), present in pAT4/8, 
could not be sequentially attached to the others prior to cloning into the vector. To 
achieve the final construct, a three way ligation was set up. The section corresponding to 
the cloned oligonucleotides was removed from pAT123 by MluUClal restriction 
digestion, and the 240 bp fragment was purified. The oligonucleotides 4+8 were 
removed from pAT4/8 by restriction digestion with ClaUBamHl and the 80 bp fragment 
was gel-purified. These were ligated with pAT3 which had been digested with Mlul and 
BamHI and gel-purified. The construction, pAT4, is illustrated in Figure 3.10.
After transformation of the E. coli strain DS941, colonies were patched out, and the 
cloned plasmids were observed on a single colony gel. Alkaline lysis mini-preps (Section 
2.9.2a) were prepared from patches showing the presence of the correct sized plasmid.
CASSETTE
SEQUENCE
aCGCGTCTCAACCAGCCAGCAGTCCCTCGATATTCAGATCA
tgcgcAGAGTTGGTCGGTCGTCAGGGAGCTATAAGTCTAGT
Hindi II
- 1 - _________________________________________________________________________________________________________
GAGCGCTCAAAGATGCAGGGGTAAAAGCTAACCGCATCTTTACCGACAAAGCTTCCGGCAG
(G) (A)
CTCGCGAGTTTCTACGTCCCCATTTTCGATTGGCGTAGAAATGGCTGTTTCGAAGGCCGTC
-5-
—I K_
(C) (T)
- 2 -
TTCAACAGATCGGGAAGGGCTGGATTTGCTGAGGATGAAGGTGGAGGAAGGTGATGTCATT
I I I 1 1 1 1 1  I I I  I I I I I  M i l l  I I I I I I I I  M i l l  I I  I I I  I !  M i l l  I M M  I I I  H I M  I
AAGTTGTCTAGCCCTTCCCGACCTAAACGACTCCTACTTCCACCTCCTTCCACTACAGTAA
Age\
- 6 -
(TCIHK
-3-
CTGGTGAAGAAGCTCGACCGGTTTGGCCGCGACACCGCCGACATGATCCAACTGATAAAAG
GACCACTTCTTCGAGCTGGCCAAACCGGCGCTGTGGCGGCTGTACTAGGTTGACTATTTTC
-7-
C/al
( t ) ( c l— 4/
AGTTTGATGCTCAGGGTGTAGCGGTTCGGTTTATCGATGACGGGATCAGTACCGACGGTGA
TCAAACTACGAGTCCCACATCGCCAAGCCAAATAGCTACTGCCCTAGTCATGGCTGCCACT
Psfl BamW
-4- f(G) (T) H b
TATGGGGCAAATGGTGGTCACCATCCTGTCTGCAGTGGCACAGGCTGAACGCCGGAGgatCC
ATACCCCGTTTACCACCAGTGGTAGGACAGACGTCACCGTGTCCGACTTGCGGCCTCCTAGg
- 8 - (C) (A)
Figure 3.8 Diagram of Til? resolvase gene cassette in pAT4
The diagram illustrates the positions of the newly introduced restriction sites relative 
to each other. Changes introduced by the oligonucleotides are shown, and the wild- 
type sequence is shown above and below the oligonucleotide sequence in bold. 
Sequence outwith the oligonucleotide length is denoted by lower case letters.
Ap pMTL23 
2505 bp
- 5 -
pAT1/5 pAT23/67
-4-
pAT4/8
Figure 3.9 Oligonucleotide Assembly
This diagram illustrates the cloning vector pMTL23 and the relative positions 
of the restriction sites flanking the oligonucleotides used to construct the gene 
cassette. The plasmids resulting from the cloning of the oligonucleotides are 
also shown, pATl/5, pAT23/67 and pAT4/8.
a)
-3- 0 s
pAT23/67
Gel purify cloned oligonucleotides 1 and 5 from pAT 1/5 on an acrylamide 
gel. Gel purify pAT23/67 large fragment when restricted Mlul - HindTH.
Ligate these fragments together.
-3- G
pAT123
b)
-7-
-4-
pAT3
Fragments containing ohgonucleotides were purified from pAT4/8 and pAT123 
and cloned into pAT3 restricted Mlul - BamHI.
i
pAT4
Figure 3.10 Assembly of pAT4
Illustration of the cloning steps involved in the assembly of the 
oligonucleotides comprising the cassette into the p-SELECT-1 based vector, to 
create pAT4.
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Various restriction digests were then carried out to ensure the presence of all the required 
restriction sites in the correct order (data not shown).
The construct, pAT4 (Figure 3.6) was then checked for resolvase production using the 
galK  system (see Section 3.2). The whole open reading frame of the gene was then 
sequenced on an automatic sequencer (at Strathclyde University). It was confirmed that 
all oligonucleotides were present in the correct order and that there were no secondary 
mutations. However, subsequent analysis of this region revealed an error which had 
been incorporated in the design of the oligonucleotides. While introducing the restriction 
site Age I, the amino acid at position 69, a leucine residue was inadvertently converted to a 
phenylalanine residue (CTT changed to Ti l ). This change was later corrected by re­
creating the oligonucleotides stretching from the Age I site to the Clal site, and amending 
the TTT to TTA which returns the residue to a leucine. This plasmid was named pAT5.
3.3.4. Test screening o f pAT4
In order to test the mutagenesis plasmid, pAT4, the following experiment was carried 
out.
CaCl2 competent cells were prepared from DS941 strains harbouring the resolution 
screening plasmids, pDB34, pDB35, pDB36 and pDB37 (Figure 3.2). Cells were 
transformed with pAT4, and after a 90 minute expression step, were spread on 
MacConkey galactose agar plates containing ampicillin and kanamycin (see Section 2.4). 
The plates were incubated overnight at 37°C, after which colonies were observed.
As predicted, only pDB34 containing two complete res sites in direct repeat was resolved 
in cells transformed with pAT4, as indicated by the presence of white colonies showing 
that the galK  gene had been excised during resolution. The strains containing the other 
plasmids, pDB35, pDB36 and pDB37, showed only red colonies, indicating the presence 
of the galK  gene, and thus a lack of resolution (Figure 3.11).
The products of these in vivo tests were then visualised on an agarose gel, by patching 
out red and white colonies and growing overnight on L-agar plates, then subsequently
Figure 3.11 Resolution of pDB34 (res v res) and pDB35 (site I v site I) 
by pAT4
Plates and close ups of (a)white colonies (indicating resolution) of 
pDB34 and (b) red colonies (no resolution) of pDB35, by pAT4. 
Even though pAT4 contained the change L69F, it maintained a 
wild-type activity in this in vivo galK  assay.
>
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examining the DNA on a Single colony gel (Section 2.23). As illustrated in Figure 3.12, 
tracks from the white colonies (resolved pDB34) show the presence of the smaller 
resolved product, which retains the origin of replication, from pDB34.
3.4 Summary
This chapter has described the development of a suitable plasmid for the purposes of 
mutagenesis. Initial attempts to insert the appropriate restriction sites, by site-directed 
mutagenesis, proved unsuccessful. The problem was overcome by an alternative 
approach of cassetting the required region of the resolvase open reading frame. The 
successful construction of this cassette led to the formation of pAT4 (later pAT5), a 
plasmid with all the requirements for mutagenesis. Using the galK in vivo screen, this 
plasmid was shown to express wild-type resolvase.
The compatibility of pAT5 with the galK in vivo screen (see Section 3.2) allowed us to 
screen the region of the gene (comprising the E-helix) for the isolation of a mutant 
resolvase able to catalyse recombination in vitro between two site Fs on a plasmid 
(Chapter 4). The cassetting of two thirds of the gene also allowed future specific or 
random mutagenesis to be carried out on a large region of the gene using the simple 
procedure of inserting mutant oligonucleotides of a relatively manageable size. Indeed, 
work has already been carried out in order to cassette the remaining one third of the 
resolvase gene, allowing mutagenesis to be carried out throughout its entire length (A. 
MacDonald, personal communication). The cassette also inserted the restriction site Pstl, 
which exists in the open reading frame of y8 resolvase, allowing hybrid constructions of 
Tn3 and yS resolvase and mutants thereof to be made.
1 2 3 4 5 6 7 8 9  1011
6.0 kb
5.0 kb
4.0 kb
3.0 kb
2.0 kb
1.6 kb
supercoiled substrate (8.37 kb) 
pAT4 (6.2 kb).
supercoiled Kmr product (4.1 kb)
Figure 3.12 Analysis of Resolution products of pDB34 by Single colony gel
Resolution of pDB34 by resolvase encoded on pAT4. DNA from white 
colonies showing resolved Kmr resistant plasmid lacking the galK  gene.
Lanes 1 - 1 kbp ladder.
2 - 10 - DNA from "white" DS941/pDB34/pAT4 colonies.
11 - DNA from DS941/pDB34 (not transformed with pAT4).
Chapter 4
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Mutagenesis of Tn3 resolvase
4.1 Introduction
Once the development of the mutant selection system (see Chapter 3) was complete, it 
was possible to proceed with the mutagenesis steps to create resolvase mutants. After 
construction of the mutants, an in vivo screen could be used to isolate and characterise 
them (Blake, 1993; see Chapter 3). This chapter describes the construction and isolation 
of Tni resolvase mutants. The techniques employed included site-directed mutagenesis 
by cloning oligonucleotides which had been synthesised with specific altered codons, in 
order to create specific mutants, and the random mutagenesis of a desired region within 
the open reading frame to construct a library of mutants for screening, by cloning 
randomly altered synthetic oligonucleotides. A specific mutant was also constructed by 
the direct cloning of synthetic oligonucleotides between two restriction sites.
Two specific mutants were made. The first of these was Y6F. The tyrosine-6 residue of 
Tn3 is conserved throughout the resolvase family, and is only four residues upstream 
from the serine residue which has been implicated in the catalysis of DNA strand 
breakage and rejoining (Hatfull and Grindley, 1988). Examination of the crystal 
structures of y5 resolvase shows that these residues are close in spatial terms. It was 
hoped that the construction of the Y6F mutant would clarify this residue’s role in 
catalysis. Changing the tyrosine residue to phenylalanine simply removes the hydroxyl 
group on the tyrosine, a potential nucleophile. Though evidence supported the serine 
residue at position 10 as the critical nucleophile (Reed and Moser, 1984; Hatfull and 
Grindley, 1986; Mazzarelli et a i, 1993), proof was not conclusive, and the existence of 
the highly conserved tyrosine-6 residue in such close proximity was potentially 
significant.
The second specific mutant to be made, E124Q, was deemed desirable after observation 
of the equivalent mutant’s properties in y5 resolvase (M. Boocock, personal 
communication). This mutant was found to have a hyperactive phenotype in comparison 
to the wild type protein. The protein was found to be catalytically active in vitro on a 
wild-type substrate, producing the normal 2 noded catenane as the product. However,
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the same reaction was also found to result in free circles and intermolecular products not 
normally associated with the wild type in vitro reaction. Unlike the wild type resolvase, 
the y5 E124Q protein was also found to be active on linear substrates, and to promote 
resolution on a substrate plasmid containing a complete res site and site I.
As previously mentioned, it was a priority to isolate a resolvase mutant which could 
promote recombination between two site I’s on a supercoiled plasmid, in the absence of 
the accessory sites II and El (see Chapter 3). Utilising the resolvase mutant selection 
system described in Chapter 3, a random mutagenesis protocol was employed to search 
for a mutant with this phenotype. As described in Section 3.1, the targeted region of the 
resolvase open reading frame was between amino acid positions 94 and 121, which 
stretches between the unique Clal and BamHI restriction sites in pAT4 (Figure 3.6), and 
corresponds to most of the E-helix seen in the y8 resolvase crystal structures.
4.2 Construction of the Tn3 resolvase Y6F mutation
The method employed to make a resolvase containing the mutation from tyrosine at 
position 6 in the resolvase open reading frame to phenylalanine, was site-directed 
mutagenesis using the p-SELECT-1 protocol (Altered Sites in vitro mutagenesis system 
technical manual, Promega). This involved annealing an oligonucleotide containing the 
codon change from tyrosine to phenylalanine (TAT to TTT) along with a second 
oligonucleotide which repaired the defective ampicillin resistance gene in p-SELECT-1, 
and allowed for a means of selection for possible mutants. The principle is, that an 
isolate which has annealed one oligonucleotide has a high chance of annealing the second 
(Figure 4.1).
Using the plasmid pDB6020 (Blake, 1993) which contains the Tni resolvase gene cloned 
into the pSELECT-1 polylinker, single stranded DNA was prepared by nicking the DNA 
with DNase I/ethidium bromide (Section 2.16), then denaturing the singly nicked plasmid 
molecules with 2 M sodium hydroxide. The standard "Altered Sites" protocol uses 
bacteriophage to make the single stranded DNA. However, the DNase I method has been 
shown to produce single stranded DNA which can be used for mutagenesis (M.
Boocock, personal communication). Subsequent site-directed mutagenesis was carried
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out as described (Altered Sites technical manual, Promega). The steps involved in this 
procedure are outlined in Figure 4.1. The Y6F oligonucleotide also contained changes 
which introduced a Mlul site, as a further means of detection of possible mutants. The 
Y6F and Ap repair oligonucleotides are detailed in Figure 4.2.
The reaction mixture (see Section 2.15) was used to transform competent EMI cells (see 
Table 2.1) which had been prepared as described in Section 2.7. EMI is a repair 
deficient (mutL) strain. One tenth of the transformation mixture was plated onto 
ampicillin plates, and the remainder was grown up overnight in 20 ml L-broth containing 
ampicillin. Two colonies were observed on the ampicillin plates, suggesting a total of 
about 20 transformants.
Two alkaline lysis mini preps were carried out (see Section 2.9) on, a) 1.5 ml of 
overnight culture; b) 1.5 ml overnight culture and picks of the two colonies. Restriction 
digestion with Mlul was then carried out on the two mini-preps (see Section 2.10). 
Visualising the DNA on a 1.2% agarose gel (see Section 2.22) showed that a proportion 
of each DNA sample had been cut with Mlul in both cases. This indicated the presence of 
a possible Y6F mutant, since the Mlul site is present on the same oligonucleotide as the 
Y6F mutation.
After transforming DNA into DS941 competent cells, Apr transformants were isolated. 
Twelve transformants were grown up overnight, and alkaline lysis mini prep DNA was 
prepared from them (see Section 2.9). The DNA was digested with Mlul, and five of the 
twelve plasmids were found to contain a Mlul site, indicating that they might also contain 
the Y6F change.
It was important to confirm that isolates containing the Mlul restriction site also contained 
the change at position 6 to phenylalanine, with no secondary mutations. CsCl DNA was 
prepared (see Section 2.9) of the five isolates, and the DNA was sequenced (see Section
2.17). Sequencing over the region where the oligonucleotides annealed showed the 
presence of the Y6F mutation in four of the five isolates. No unexpected secondary 
mutations were observed throughout the region of the resolvase open reading frame 
which was sequenced.
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The recombinational activity of the Y6F resolvase encoded on the pDB6020-derived 
plasmid, pATY6F, was then examined in vivo using the galK screen (see Section 3.2). 
The results of this screen are shown in Section 4.5. The protein was then purified in 
order to observe its in vitro properties (Chapter 6).
4.3 Construction of Tn3 resolvase E124Q mutation
The construction of the mutant E124Q resolvase was carried out in the expression 
plasmid pSAl 101 (Figure 3.5). This plasmid contained the required unique restriction 
sites, Eagl and BamHI, flanking the E l24 codon, which would be essential to the 
strategy employed.
The strategy for mutagenesis was as follows. E l24 lies between the BamHI - Eagl 
restriction sites in pSAl 101 (Figure 3.5). It was decided to make two complementary 
oligonucleotides which are equivalent to the DNA between these restriction sites, but 
contain the change at position 124 altering the glutamic acid codon (GAG) into a 
glutamine codon (CAG), along with the introduction of a unique restriction site BsiWi 
(see Figure 4.3). These oligonucleotides could then be cloned into pSAl 101 (see Section 
2.2)) which had been digested with BamHI and Eagl (Section 2.15).
Oligonucleotides were synthesised, and purified in the usual manner (Section 2.21). The 
two oligonucleotides were annealed (10 pmol of each; see Section 2.20).
An overnight ligation was then set up (Section 2.15) comprising annealed oligonucleotide 
and gel-purified digested pSAl 101. Transformation with the ligation mixture resulted in 
six colonies on L-agar plates containing kanamycin. From overnight cultures of the six 
transformants, DNA was prepared (Section 2.9.2). Restriction digests with BsPNl 
showed the presence of the restriction site in five of these six clones. These five clones 
were sequenced over the length of DNA between BamHI and Eagl restriction sites and 
were all shown to contain the required mutation with no secondary mutations present. 
This plasmid was named pATXE124Q.
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In order to test the in vivo properties of E124Q resolvase, the Kpnl - BamHI restriction 
fragment of pATXE124Q, containing the resolvase open reading frame, was used to 
replace the equivalent section of pAT5 (Work carried out by Martin Boocock; see also 
Section 4.5). The protein was also purified for further in vitro work (see Chapters 5 and 
6 ).
4.4 Random mutagenesis of Tn3 resolvase
The reasons have been previously described for the mutagenesis of the region contained 
between the BamHI and Clal restriction sites in the open reading frame of Tni resolvase 
(see Chapter 3).
In order to ensure, as far as possible, that amino acid substitutions occurred randomly 
throughout this region, the following method was employed. Oligonucleotides were 
synthesised which stretched the 80 bp between these two restriction sites, and contained 
randomly altered bases throughout the length of this region. This was achieved by 
"spiking" each of the four base reagents used to synthesise the oligonucleotides with the 
other three, such that (along the length of the oligonucleotide) the "wrong" base would be 
inserted randomly, resulting in the possibility of an alternative amino acid being encoded. 
These oligonucleotides were to be cloned into the resolvase open reading frame, and a 
library of mutants constructed (Figure 4.4), which could then be screened with a variety 
of test plasmids to isolate potentially interesting mutants.
4.4.1 Synthesis of oligonucleotides
In the main, synthesis of the oligonucleotides used was by the usual method (Section
2.18), with the exception of the four base bottles used for the synthesis.
The lengths of the two complementary oligonucleotides stretching between the Clal and 
BamHI restriction sites are 84 and 86 bp. It was decided to add 1% of each of the 
“wrong” bases to each phosphoramidite reagent, which should lead to about 2.5 base 
changes per oligonucleotide. Since not every base change will result in an amino acid 
substitution, this should result in about 2 amino acid changes per oligonucleotide, on
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average . It was decided to spike both oligonucleotides for two reasons. Firstly, all 
plasmids obtained will have been derived from a mutant strand, resulting in a lower 
background of “wild-type”. Mutating both strands also removes any preferential bias of 
the repair system towards one strand, thus, for example, giving biased corrections to 
wild-type.
Equal quantities of solutions of each of the four base phosphoramidites were mixed. This 
mix was added to fresh bottles of each of the four phosphoramidites, adding sufficient to 
give 1 % of each “wrong” phosphoramidite. These contaminated bases were then used to 
synthesise the oligonucleotides in the standard manner.
The oligonucleotides made (M4 + M8) were then purified on a 10% polyacrylamide 
denaturing gel (Section 2.22) and eluted from the gel (Section 2.21). The concentration of 
the oligonucleotides was determined (Section 2.27). The oligonucleotides, M4 and M8, 
were then annealed to each other.
4.4.2 Construction of a library of mutants
The vector into which M4 + M8 were to be cloned, pAT4 (Figure 3.6) was digested with 
BamHI and Clal, and the large 6.15 kb fragment was gel-purified on a 1.2% agarose gel 
(Section 2.22). A ligation was then set up between this DNA fragment and the annealed 
mutated oligonucleotides. Approximately 0.125 pmol of large DNA fragment, and 0.25 
pmol of annealed oligonucleotides were used in the ligation.
Half of the ligation mix was used to transform DS941 competent cells. In order to 
minimise the number of duplicate transformants resulting from a single cloning event, the 
expression step, which normally lasts 90 minutes was reduced to 15 minutes. This 
allowed the cells to recover but prevented subsequent generations. When plated onto 
ampicillin plates, 500 transformants were observed. In principle, each transformed cell 
may have two types of plasmid in it, derived from the two strands of the ligated plasmid. 
However this problem disappears on subsequent transformation of the library DNA into 
the strain containing the test plasmid. In order to make a DNA library of these mutants, 
the transformants were pooled by resuspending the colonies in 3 ml of L-broth. The cells
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were then spun down, and DNA was prepared by the alkaline lysis method (see Section 
2.9). This provided the first library, LI. A control ligation, containing restricted pAT4 
DNA but lacking the oligonucleotides, had been carried out to check the efficiency of 
enzyme cutting. When transformed, this ligation resulted in a very small number of 
colonies.
The remainder of the ligation mix was transformed into DH5a competent cells (supplied 
by BRL), which were highly competent. This transformation resulted in 2000 colonies 
from which a second library was constructed as described in the previous paragraph, and 
named L2.
These libraries were then screened (Section 4.5.2) for the presence of mutants.
4.5 In vivo analysis of Tn3 resolvase mutants
Using the galK in vivo screen, the specific mutant resol vases encoded by pATY6F and 
pAT5E124Q, were examined for their recombinational activity. The screen was also used 
to isolate mutants with a particular phenotype from the libraries created, LI and L2. 
pAT4, which contains the L69F mutant resolvase open reading frame inadvertently 
created during its construction (see Section 3.3.3) was also examined.
The mutation E124Q which had previously only existed in the expression plasmid (based 
on pSAl 101) was cloned into the pSELECT-1 based pAT5 as a Kpnl - BamHI fragment 
swop (M. Boocock, personal communication).
4.5.1 Analysis o f specific mutants
The three mutant plasmids pATY6F, pAT4 and pAT5E124Q were used to transform 
DS941 strains containing the screening plasmids pDB34, pDB35, pDB36 and pDB37 
(see Chapter 3; Figure 3.2). The strains were also transformed (see Section 2.8) with 
pDB6020 (see Section 2.2), a plasmid which expresses low levels of wild-type 
resolvase, to act as a positive control. After plating onto MacConkey galactose plates, 
resolution of the substrate plasmid results in the observation of white/yellow colonies,
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while colonies in which the plasmid is not resolved are red (see Chapter 3). Figure 4.5 
depicts the results of these transformations.
The wild-type plasmid pDB6020 resolves only the wild-type substrate, pDB34, 
containing two complete res sites in direct repeat. The pAT5Y6F mutant fails to promote 
this reaction, and thus Y6F resolvase would seem to be catalytically dead for 
recombination. The pAT5E124Q mutant behaved as would a wild-type resolvase in vivo, 
i.e. resolving pDB34 (containing two wild-type res sites), but with no resolution 
observed with the plasmids containing partial res sites. This was not entirely expected, as 
the y8 E124Q mutant resolves res v Site I in vivo using this assay (M. Boocock, personal 
communication). The mutant pAT4(L69F) also showed recombinational activity typical 
of the wild-type protein. pAT5, which is identical to pAT4 except for correction of the 
L69F mutant to wild-type, behaved exactly as pAT4 in this assay (data not shown).
4.5.2 In vivo screening of the libraries, LI and L2
DS941 strains containing the four screening plasmids, pDB34, pDB35, pDB36 and 
pDB37 (Blake, 1993) were then used to isolate potentially interesting resolvase mutants 
from the libraries made in Section 4.4.
As in Chapter 3, CaCh competent cells were prepared (see Section 2.7) from DS941 
strains containing these plasmids. 3 jig of library DNA was used to transform the 
competent cells, and these were then plated onto MacConkey galactose plates containing 
Ap and Km. Over 2000 colonies were observed for each transformation, to ensure that 
screening had been complete.
pDB34 (res v res) transformants showed a roughly 50% split between reds/whites. This 
indicates a mixture of functional and non-functional resolvase mutants, which was 
expected since the mutagenesis was aiming for 1-2 substitutions per oligonucleotide 
length. Some substitutions may result in a conservative change, or a change at a non- 
essential residue, whereas others may be very damaging to activity.
*o
rj
(b)
Figure 4.5 In vivo screening of Library I
Illustration of the red and white colonies observed when the mutant Library-1 
was screened with the wild-type substrate pDB34.
(a) Photograph of the whole MacConkey galactose plate
(b) Close up of a section of the plate.
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When DS941 containing pDB35 (site I v site I) was transformed, all colonies observed 
were red, indicating that no mutant had been isolated which could promote resolution 
between two single site I* s. This was initially disappointing. However, this may indicate 
that the phenotype required to catalyse this reaction may not be conveyed by a single 
amino acid change, and perhaps a more severe mutagenesis, or combination of mutants 
was required.
Screening the library with pDB36 and pDB37 (site I v res) resulted in a total of 8 colonies 
which were white (Table 4.1), suggesting that the plasmids containing only one full res 
site and a site I had been resolved. These isolates were then restreaked onto fresh 
MacConkey galactose plates containing ampicillin and kanamycin to ensure the 
reproducibility of the test. All eight isolates were found to form white colonies on 
restreaking, and thus had apparently resolved the plasmid.
TEST
PLASM ID
LIBRARY 1
(from 500 transformants)
LIBRARY 2
(from 2000 transformants)
Red colonies
(No resolution)
W hite colonies
(Resolution)
Red Colonies
(No resolution)
W hite colonies
(Resolution)
pDB34 
{res v res) - 4 8 0 0 - 5 2 0 0 - 4 9 0 0 - 5 1 0 0
pDB35 
(sitel v sitel) - 1 0 0 0 0 - 1 0 0 0 0
pDB36 
{res v sitel) - 1 0 0 0 0 - 1 0 0 0 0 3
pDB37 
{res v sitel) - 1 0 0 0 0 - 1 0 0 0 0 5
Table 4.1: Screening of mutant libraries
The eight isolates were then grown up, and mini CsCl DNA preps were carried out 
(Section 2.9.2). The DNA of the pAT4 derivatives was then sequenced. In all cases a 
change was observed at position 102 (GAT - TAT), which resulted in the amino acid
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residue being altered from aspartate to tyrosine. Since this mutant displayed a novel 
phenotype, it was then purified for in vitro work (see Chapter 6). Retransformation of 
pAT4D102Y into DS941/pDB36 and DS941/pDB37 reproduced the previously observed 
resolution; all colonies were white on MacConkey galactose plates. It was also shown by 
single colony gel analysis (see Section 2.23) that pDB36 and pDB37 had been resolved. 
pAT4D102Y retransformed into DS941/pDB34 gave white colonies, showing resolution 
of the two res test plasmid, as expected, while transformation into DS941/pDB35 gave 
only red colonies, indicating that the D102Y mutation had not conferred activity on a site I 
v site I substrate (Figure 4.6).
This mutagenesis experiment was repeated subsequently (M. Burke, personal 
communication) using the same “spiked” oligonucleotides, but cloning into pAT5 (wild- 
type at position L69). Further mutants that can resolve pDB37 were isolated; all turned 
out to be mutant at D 102 (see Chapter 7).
4.5.3 Sequencing of library mutants
In order to investigate the resolvase reading frame (Clal - BamHl) of the mutant pAT4 for 
the extent and range of mutants contained in the library, it was decided to sequence both 
red and white colonies obtained by screening the libraries with the wild-type substrate 
plasmid, pDB34. This would result in the identification of mutants which have lost the 
ability to carry out resolution by a single amino acid substitution. Also, mutants which 
contain amino acid substitutions but retain their function could be identified.
The colonies were re-patched onto L-agar plates containing ampicillin, and overnight 
cultures were set up in L-broth containing ampicillin. DNA was prepared from the 
overnight cultures by the mini CsCl method (see Section 2.9.2) and sequenced. Figure 
4.7 shows the positions of some of the mutants isolated.
Sequencing the library mutants also showed that approximately 80% of the white colonies 
were in fact wild-type, and contained no codon changes. This indicated that the library 
was perhaps not as extensive as we would have hoped. This problem may be overcome 
by creating a library using oligonucleotides which have been synthesised with a higher
res X res res X site I site I X site I
pD B34 pD B37 pDB35
wt
D102Y
Figure 4.6 In vivo properties of pAT5 and pAT5D102Y
Figure shows that mutant pAT5Dl02Y can resolve both pDB34 (res v res) and 
pDB37 (res v site I) but cannot resolve pDB35 (site I v site I). pAT5, the wild- 
type control plasmid, can only resolve the wild-type substrate pDB34. In this in 
vivo galK  assay, white colonies contain recombinationally active resolvases, 
while red colonies are recombinationally dead.
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percentage of altered codons. Also, ensuring that the vector used in the ligation with the 
oligonucleotides contains no full length linear DNA which may recircularise during the 
ligation, may reduce the percentage of white colonies containing plasmid with the wild- 
type sequence. A large proportion of red colonies (no resolution) had frame shifts in the 
Clal - BamHl sequence. This problem may be due to the method of randomising the 
mutation using oligonucleotides, and might be strain-dependent..
4.6 Analysis of the mutagenesis procedure
It is important to confirm that the mutations introduced by the random mutagenesis 
procedure were indeed random, and that there was no bias for specific base substitutions, 
such as transitions over transversions or vice versa. In order to do this a few calculations 
were carried out.
4.6.1 Base Replacem ents
There are twelve base replacements in total (each base can be mutated to three others). 
However, because mutagenic oligonucleotides were used to replace both strands of the 
DNA in the Clal - BamHl region, there are only six possibilities to be considered; e.g. a 
G-C base pair which is mutated to a T-A base pair could have been caused by either a G 
to T change on one strand or a C to A change on the other DNA strand.
The point mutations in the Clal - BamHl region, detected by sequencing of isolates from 
the libraries of mutated pAT4, are summarised in Table 4.2.
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Base Replacement Number of Occurrences
I G -> A / C -> T 7
I A -> G / T -> C 10
V G -> T / C ->A 13
y G -> C / C -> G 14
V A -> C / T -> G 8
V A -> T / T -> A 12
Table 4.2 : Occurrence of Base replacements
From these data we can see that all possible base changes have been made, and though 
some have a slightly higher frequency than others, the differences in this relatively small 
data set are not statistically significant.
From Table 4.2 we can see that there were 17 transitions and 47 transversions 
(distinguished by the letters "I" and "V" in the table). If mutagenesis were truly random, 
there should be twice as many transversions as transitions. Again, the excess of 
transversions observed is probably not significant because of the small sample size.
4.6.2 Positions of the mutations
It was interesting to examine the positions of the point mutations, to determine whether 
mutations in the first and last 10 bp of the targeted region had an effect on the ability of 
the oligonucleotide to ligate efficiently at the restriction sites. Nine mutations were found 
in the first 10 bp of the targeted region, and only two in the last 10 bp. The middle 
section, of 64 bp, contained 53 mutations (Figure 4.8). There is no obvious bias against 
mutations at the beginning of the targeted region; the small number at the BamHl end of 
the sequence may indicate a slight bias, or could simply be a statistical aberration due to 
the small number of isolates sequenced.
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From this evidence, it can be deduced that mutagenesis is indeed random, with no bias 
towards a specific base substitution, or type of substitution, or sequence region. This 
differs from other methods of mutagenesis such as PCR or chemical mutagenesis, both of 
which result in a bias towards certain types of alteration.
4.7 Analysis of mutant libraries
The combined libraries, LI and L2 contained 2500 individual colonies. However, the 
number of independent mutants of pAT4 was inevitably less than this. Sequencing of 
DNA derived from 50 pAT4 "white" colonies (recombinationally active) from the galK 
assay with a wild-type substrate plasmid, pDB34, showed that 13 contained one or more 
base substitutions ( i.e. 26%). Since 50% of colonies obtained by transformation with 
libraries were white, about 13% of the total 2500 colonies were recombinationally active 
on the wild type resolution plasmid but contained base substitutions, i.e about 325 
colonies. The remainder of the "white" colonies isolated (harbouring unmutated pAT4) 
could have arisen by several routes. Firstly, they could be derived from the vector DNA. 
Some of the pAT4 vector DNA may have only been cut at one of the two restriction sites, 
and as a result could simply have recircularised on ligation without incorporation of any 
mutant oligonucleotide. Secondly, some of the oligonucleotides containing substituted 
bases may have been repaired to the wild type sequence existing on the second strand. 
Finally, some oligonucleotide may simply have contained no mutations. Since it was 
estimated that the oligonucleotides would contain 2 base substitutions each on average, it 
is safe to assume that some may contain no changes.
Sequence analysis of 36 pAT4 mutants with a recombinationally inactive phenotype, 
giving "red" colonies in the assay with pDB34, the wild-type substrate, showed that 25 
of these contained frameshifts (i.e. 69%), with the remaining 11 containing one or more 
base substitutions. This means that about 31 % of the total "red" colonies harboured 
pAT4 encoding full length mutant resolvase, and this computes to 15.5% of the total 
isolates within the libraries, i.e. about 387 clonies. It should be noted that the frameshifts 
were exclusively single base pair insertions or deletions of up to 5 bp. There was no 
evidence of large insertions or deletions.
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In order to avoid a number of isolates resulting from the same transformation event, a 
very short expression step was carried out during transformation (see Section 4.4.2). 
Therefore we can be relatively confident that the libraries contain approximately 712 
mutants with either single or multiple base substitutions. Considering that of the 82 bp 
targeted, the number of possible single base substitutions is 246, the libraries contain 
almost 3 (2.89) times this number of mutants. We can therefore be confident that most of 
the possible single substitutions were screened. However, any codon can only be 
changed into 9 other codons by mutation at a single base pair, and some of these may 
encode the same amino acid. Thus this type of mutagenesis does not create every 
possible amino acid change at each residue.
Taking this into account, it seems possible that position 102 is the only position in the 
targeted region of Tni resol vase which can yield a hyperactive point mutant active on a 
plasmid containing a site I in direct repeat with an entire res site, and detectable by this 
assay. Position 124 (not in the Clal - BamHl fragment) when mutated from glutamate to 
glutamine in y8 resol vase resulted in a hyperactive mutant of this phenotype. However, 
the same mutation created in Tn5 resolvase (see Chapter 6), while obviously displaying 
hyperactive tendencies in comparison to the wild type protein, is not sufficiently active to 
promote the site I v res reaction in vivo or in vitro, and would not have been detectable by 
this assay. This mutant may prove to display a more hyperactive phenotype in 
conjunction with other mutations (see Chapter 7).
4.8 Summary
The specific resolvase mutants, Y6F and E124Q were created and their properties were 
analysed in vivo. As expected, the Y6F protein was recombinationally inactive, but the 
E124Q protein was shown to behave unlike the y8 E124Q resolvase equivalent. The Tn3 
resolvase mutant, in vivo, seemed to behave as the wild-type protein, and displayed none 
of the hyperactivity of the y5 protein, which resolves substrates containing site I in direct 
repeat with res. However, it was hoped that in vitro analysis would yield further 
information concerning the properties of this protein. L69F resolvase (pAT4) also 
exhibited wild type behaviour (i.e. the same as pAT5).
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Two random mutagenesis libraries were created, and screening revealed a Tn3 resolvase 
mutant, D102Y, which resolved a substrate containing site I in direct repeat with res.
The libraries did not contain a mutant which was able to resolve substrates containing two 
site I’s. Sequencing of DNA from both red and white colonies resulting from screening 
with the wild type plasmid containing two res sites (pDB34) led to the identification of 
point mutations that caused inactivation of resolvase (red colonies) or did not prevent 
resolution (white colonies). It was also observed that a the libraries created contained a 
significant number of frameshifts and unmutated reading frames. Amendment of the 
procedure to create the libraries may help remove these unwanted isolates.
The galK  screen used has proved to be very successful in the isolation and 
characterisation of resolvase mutants. Though the screen requires a relatively low rate of 
resolution in order to observe the “white colony phenotype” due to the low copy number 
of the test plasmids, it does require complete resolution of all plasmids in the cell to take 
place. However the screen has proved to be remarkably accurate in isolating mutants, 
whose in vivo phenotype was similarity displayed after purification, in the in vitro assay. 
It is therefore a very useful tool in the search for mutants which perform specific 
recombinational activities in vitro.
Chapter 5
Development of a new expression and purification system for Tn3
resolvase
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Development of a new expression and purification system for 
Tn3 resolvase
5.1 Introduction
Since the aims of this project required the purification of a range of resolvase proteins 
containing mutated residues, for in vitro work, it was essential that a good system for 
over-expression of these proteins was available, along with a reliable and reproducible 
protein purification system.
The expression system in existence used a plasmid based on pKK223 (Brosius and Holy, 
1984). In derivatives of this plasmid, expression of the targeted protein is driven by 
IPTG induction of the tac promoter, lying upstream of the gene of interest. For Tni 
resolvase, induction of E. coli cells containing the pKK223-derived plasmid pMA6114 
(Blake, 1993) with IPTG resulted in very poor growth in the strain JM101; over­
expression of resolvase was observed to a reasonable degree, and JM101(pMA6114) was 
used for all the TnJ resolvase preparations previously carried out in this lab (Blake, 1993; 
Watson, 1994).
In order to achieve higher expression of resolvase, it was decided to construct a new 
expression plasmid based on one of the pET plasmids. These employ a promoter 
recognised by the phage T7 RNA polymerase, but not by the host E. coli RNA 
polymerase. Protein is produced on expression of the T7 RNA polymerase, either by 
phage infection, or by induction with IPTG of strains (e.g. BL21(DE3)) containing 
integrated copies of a T7 polymerase gene (Studier et al., 1990).
Since a variety of mutants were to be made, it was desirable that the plasmid in which the 
mutagenesis was to take place would have certain features in common with the expression 
plasmid (such as unique compatible restriction sites flanking the resolvase open reading 
frame), and this was kept in mind when designing the expression plasmid.
A large scale purification procedure was already in existence (see above). The 
purification of resolvase in this procedure was dependent on the resolvase remaining
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soluble after the cells had been lysed by passage through a French Press, and the 
subsequent precipitation of resolvase (along with the DNA) by the addition of spermine. 
When the resolvase was redissolved it was found to be relatively pure. However, great 
care was necessary to ensure that the procedure gave reproducible yields. It was not 
certain that the procedure would be applicable to all resolvase mutants. One attempt to 
use it for preparation of the mutant Y6F (Chapter 4) failed because the resolvase was 
insoluble after lysis of the cells in the French Press. It was decided to use this protocol as 
a starting point to develop a more reliable procedure.
In a small scale variation of the protocol (Blake, 1993), it had been found that the 
resolvase, instead of remaining in solution as in the large scale purification, tended to 
pellet along with the cell debris after lysis of the cells. Getting the resolvase to remain in 
solution at this point proved problematic, and so an alternative strategy was devised, 
involving recovery of the denatured protein from the pellet and subsequent refolding.
This denaturing procedure had the added advantage of protecting the resolvase against the 
action of proteases for a large part of the protocol. Refolding was carried out by dialysis 
to remove the urea denaturant.
5.2 Construction of the expression vector, pSA llO l
5.2.1 Construction of pTAl
The first step in the construction of the expression construct involved inserting the wild- 
type resolvase open reading frame into the chosen pKET3a vector (Studier et al., 1990;
S. Rowland, unpublished). A three way ligation was carried out with the 717 bp tnpR 
fragment created by MluVHincU digest of pDB6020-Y6F (Chapter 4), along with the 
complementary oligonucleotides, AY6FT and AY6FB, which stretch from the Ndel site 
just outside the open reading frame to the Mlul site, -24 bp into the reading frame, were 
cloned into pKET3a, digested with NdeUHincll (Fig. 5.1). This step removed the 
previously created Y6F mutation at the beginning of the open reading frame, restoring the 
wild type amino acid sequence, but retaining the Mlul site, which was to be used in the 
creation of the “mutagenesis plasmid” (Section 3.3). The position of the Ndel site at the 
start codon (CATATG) means that the cloning results in the ideal spacing for the open
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Figure 5.1 Diagram illustrating the construction of pTAl.
The ORF of pDB6020-Y6F was removed by restriction digest with Mlul and 
Hincll and cloned into pKET3a digested Ndel to Hindi. The ORF which 
stretches between Ndel and Mlul was reconstructed with the oligonucleotides 
AY6F(T) and AY6F(B).
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in pET3. The wild type resolvase open reading frame was downstream of the T7 phage 
promoter in the new vector, pTAl (Figure 5.1). pTAl was sequenced over both ligated 
ends to ensure that the oligonucleotides and open reading frame had inserted as predicted.
5.2.2. Induction of pTAl
In order to confirm that pTAl expressed resolvase, and to determine the level at which 
expression occurred, small scale inductions were carried out in the four BL21 strains.
pTAl was transformed into the four BL21 strains (BL21, BL21(DE3), 
BL21(DE3)pLysS, BL21(DE3)pLysE) (Studier et al., 1986). BL21(DE3) has an 
integrated prophage containing an inducible lac UV5 promoter which drives transcription 
of the T7 RNA polymerase gene. The strains BL21(DE3)pLysS and BL21(DE3)pLysE 
contain plasmids which reduce the uninduced activity of T7 RNA polymerase by the 
production of T7 lysozyme. T7 lysozyme acts as an inhibitor of T7 RNA polymerase by 
forming a complex with it. If the targeted protein is in any way toxic to the cells, 
reduction of the basal expression can optimise the growth of the culture. These plasmids 
differ in the expression of T7 lysozyme, with pLysE producing much more. However, 
this can be counter-productive since large amounts of lysozyme can inhibit cell growth 
and cause excessive lysis of cultures. It is normal procedure to test expression in the four 
strains, and choose the strain that gives the best results for further work.
Kanamycin-resistant transformants containing pTAl were grown up in liquid culture (L- 
broth) overnight to reach stationary phase. The overnight culture was then diluted 1:100 
(200 jil inoculated into 20 ml of fresh broth) and grown until the OD^oo had reached 0.4 - 
0.5. At this point, 10 ml of culture was removed to a separate boiling tube and used as an 
uninduced control. To the remaining 10 ml, IPTG (1 mM final) was added to induce the 
cells, and they were grown in a shaking water bath for 3 hours at 37 °C.
20 jil samples were then taken, spun down, resuspended in Laemmli Loading Buffer, 
and run on a Laemmli gel (Section 2.22.2) to observe whether induction had taken place. 
As the gel in Figure 5.2 shows, the new expression construct over-expressed resolvase, 
and did so to a higher level than had previously been seen with pMA6114. The protein
Figure 5.2 Inductions of BL21 strains containing pT A l
Laemmli gel showing the relative amounts of resolvase produced on 
induction of the four BL21 strains containing pTAlwith IPTG. The position 
of resolvase is indicated by an arrow.
Lanes 1 - Resolvase marker
2 - BL21/pTAl
3 - BL21/pTAl + IPTG
4 - BL21DE3/pTAl
5 - BL21DE3/pTAl + IPTG
6 - BL21 DE3pLysS/pTA1
7 - BL21DE3pLysS/pTAl + IPTG
8 - BL21 DE3pLysE/pTA1
9 - BL21 DE3pLysE/pTA1 + IPTG 
10 - Resolvase marker
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was subsequently purified and shown to be active in the standard resolution assay (see 
Section 2.33).
5.2.3. Construction of pSAllO l
The resolvase expression plasmid, pTAl, then underwent a series of cloning steps in 
order to maximise over-expression of the protein and ensure compatibility with the 
plasmid used for mutagenesis, pAT4 (see Section 3.3; Figure 3.6). This work was 
carried out by S. Rowland and resulted in the plasmid pSAl 101 (see Section 3.3; Figure 
3.5). The main results of these cloning steps were the introduction of unique restriction 
sites at the ends of the resolvase reading frame to allow the cloning of mutated resolvase 
open reading frames from pAT4 easily, and the introduction of the lac operator from 
pETlc, allowing a lower basal level of expression by the binding of the lac repressor, but 
at the same time allowing similar levels of induced expression (Figure 5.3).
5.2.4. Induction of pSAllOl
Small scale inductions (as previously described for pATl) were carried out with 
pSAl 101, and the level of expression was visualised on a Laemmli gel (data not shown), 
which confirmed that the plasmid was making resolvase to a higher level than previous 
expression plasmids.
In order to maximise protein production, the effects of time of induction and the length of 
induction were investigated.
a) Point of induction
20 ml of L-broth was inoculated with 200 pi of overnight liquid culture of 
BL21(DE3)pLysS pSAl 101. At selected intervals, 1 ml of the culture was removed and 
induced with 1 mM IPTG for 3 hours. Samples were induced over a range of ODgoo 
from 0.1 to 0.9. The OD600 at the end of the induction was also recorded and the figures 
are shown in Table 5.1.
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expression purposes pSAl 101.
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After inducing expression for 3 hours, 20 jllI samples were spun down and resuspended 
in Laemmli buffer before loading on a Laemmli gel (Section 2.22.2) (Figure 5.4). This 
gel clearly showed that the highest level of induction of resolvase was obtained by 
inducing the culture while the cells were at ODgoo of 0.3 - 0.4. However, cells induced 
at this point failed to reach as high a density as cells which were induced later. It was 
decided that the optimum point of induction was at OD600 0.4 - 0.5 .
b) Length of Induction
To determine if the length of time that the cells are induced for plays a significant role in 
the level of resolvase expression, cells were induced for varying times. A 20 ml culture 
was inoculated with 200 pi of overnight culture of BL21(DE3)pLysS (pSAl 101), and 
grown at 37 °C until the OD600 of the cells was about 0.33. 1 ml aliquots of culture were 
removed and induced with 1 mM IPTG for various lengths of time (Table 5.2).
After the cells had been induced, a 20 pi sample was spun down and resuspended in 
Laemmli loading buffer before loading on a Laemmli gel (Figure 5.5). Resolvase was 
obviously present after 1 hour, and the amount increased with time. However, after 3.5 
hours, there was little further increase. Based on this experiment, it was decided to 
induce future batches of cells for ~4 hours.
5.3 Purification of resolvase from induced 
BL21(DE3)pLysS(pSA1101) cells
In previous large scale resolvase purification protocols (Watson, 1994), after the cells had 
been induced and harvested, they were resuspended and broken by 3 passes through a 
French Press. However, in this purification, sonication was used.
Solutions & Buffers
1 x KPM : 25 mM KH2P 04 (pH 7.0), 5 mM MgCl2, 1 mM EDTA, 0.4 mM 
DTT, 1 mM benzamidine 
RHB : 2 M NaCl, 20 mM Tris-HCl (pH 7.5), 0.1 mM EDTA, 0.2 mM DTT
SAMPLE 0^600 AT 
INDUCTION
AGE OF CULTURE 
AT INDUCTION
o d 600 AT END 
OF INDUCTION
1 0.098 1 h 15 min 0.752
2 0.214 1 h 50 min 0.934
3 0.302 2 h 10 min 1.081
4 0.395 2 h 30 min 1.202
5 0.495 3 h 1.183
6 0.605 3 h 25 1.523
7 0.890 4 h 15 min 1.577
Table 5.1 The effect of time of induction
m l 2 3 4 5 6 7 u
Figure 5.4 The effect of time of induction.
Laemmli gel showing the effect of inducing B121(DE3)pLysS(pSAl 101) 
cells at various stages in the growth of the culture (i.e.increasing optical 
density). Details are listed in Table 5.1. Position of resolvase is denoted by 
an arrow.
Lanes m - Resolvase marker
1 - 7 - As indicated in Table 5.1 
u - Uninduced cells
SAMPLE LENGTH OF 
INDUCTION (min)
o d 600 AT END 
OF INDUCTION
1 0 0.33
2 30 0.427
3 63 0.525
4 95 0.594
5 120 0.678
6 200 0.784
7 240 0.804
8 420 0.875
Table 5.2 The effect of varying the length of induction
m l 2 3 4 5 6 7 8 u
Figure 5.5 The effect of length of induction.
Laemmli gel showing the effect of increasing the length of time of induction 
on BL21(DE3)pLysS(pSAl 101) cells. Details are listed in Table 5.2. 
Position of resolvase is denoted by an arrow.
Lanes m - Resolvase marker
1 - 8 - As indicated in Table 5.1 
u - Uninduced cells
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RHB : 2 M NaCl, 20 mM Tris-HCl (pH 7.5), 0.1 mM EDTA, 0.2 mM DTT 
PMSF Solution: 10 mg/ml in ethanol
Tris Buffer-1 : 20 mM Tris-HCl (pH 7.5), 1 mM EDTA, 0.4 mM DTT 
Tris Buffer-2 : Tris Buffer 1 + 100 mM NaCl 
Tris Buffer -3 : Tris Buffer 1 + 2 M NaCl
Urea Buffer-A : 7 M urea, 20 mM Tris-HCl (pH 7.5), 1 mM EDTA, 0.4 mM 
DTT
Urea Buffer-B : Urea Buffer-A + 1 M NaCl 
Urea Buffer-C : Urea Buffer-A + 2 M NaCl
At various stages throughout the purification, ~5 pi samples were taken and run on a 
 ^ Laemmli gel to follow the progress of the protein. These are shown in brackets. Several 
resolvase mutants were purified by the procedure described; the specific purification 
illustrated here is o f D102Y resolvase.
Induction of the cells was carried out as follows. 5 ml of overnight culture of 
BL21(DE3)pLysS(pATXD102Y) was inoculated into 500 ml of pre-warmed L-broth in a
2 litre flask with the appropriate antibiotics, chloramphenicol and kanamycin at a 
concentration of 50 pg/ml (final) each. Two flasks were set up, and cells were grown for
3 hours at 37 °C until the ODgoo was 0.445. 5 ml of the culture was then removed from 
the flask and placed in a boiling tube, and grown to act as a control for non-induced cells. 
IPTG was then added to both the flasks to a final concentration of 1 mM. The cultures 
were induced for 3 hours at 37 °C with shaking. Cells were then spun down in a pre­
chilled rotor at 5000 rpm for 10 minutes, then weighed and stored at -20 °C. The two 
cultures weighed 2.96 g and 2.87 g.
Ice-cold KPM Buffer (14 ml) + PMSF solution (150 pi) was added to cells thawing on 
ice, and the cells were resuspended (sample IS). The mixture was sonicated, with a 
Vibra cell VC 100 sonicator probe, on ice at 40% power, 6 x 20 seconds, with a 10 
minute gap between bursts to prevent the cells overheating. The mixture was centrifuged 
at 18 000 rpm for 10 minutes, 4 °C in a JA-20 rotor, and the supernatant was decanted 
and kept on ice (samples 2S + 2P). The pellet was resuspended in 10 ml of Tris-Buffer- 
1, and homogenised (7 ml Dounce Tissue Grinder, supplied by Wheaton) before
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centrifuging as above (samples 3S + 3P). The supernatant was removed, and the pellet 
was resuspended in 10 ml of Tris Buffer 2. After homogenising as before, the mixture 
was recentrifuged at 18 000 rpm, 10 minutes, 4 °C (samples 4S + 4P).
The pellet was resuspended in 10 ml of Urea buffer A, then homogenised thoroughly and 
left to resuspend for 1-2 hours. After which, the mixture was spun at 18 000 rpm, 15 
minutes at 20 °C. The supernatant and the pellet were kept (5S +5P) and a Laemmli gel 
was run to check the location of the protein (Figure 5.6).
Once it had been confirmed that the resolvase was present in the supernatant (sample 5S), 
it was passed down a small SP sepharose Fast Row cation exchange column ~3 cm high, 
equilibrated with Urea Buffer A. After loading, the column was washed with 5 column 
volumes of Urea Buffer A. This removed unbound protein, DNA and RNA from the 
column. The resolvase was then eluted from the column by washing with Urea Buffer B. 
5 x 1.5 ml samples were collected, and these fractions were run on a second Laemmli gel. 
The resolvase was generally observed to be in the 2nd and 3rd fractions (Figure 5.7).
The appropriate resolvase fractions were then dialysed against Tris-Buffer 1(11). The 
resolvase precipitated, and after spinning (15 000 rpm, 4 °C, 10 minutes) the pellet was 
redissolved in Urea Buffer A (400 p.1).
The sample was loaded onto a Pharmacia MonoS FPLC column (volume 400 fil), and 
washed through with Urea Buffer A until a relatively steady base line had returned. A 
gradient, varying the salt concentration from 0 to 500 mM NaCl over 60 minutes, was 
then carried out to elute the resolvase from the column at 0.5 ml/minute, and 0.5 ml 
fractions were taken. The resolvase was, in general, found to elute at between 200 and 
300 mM NaCl. Fractions containing resolvase were identified by electrophoresis on a 
Laemmli gel (Figure 5.8).
Appropriate fractions were then dialysed at 4 °C against 2 litres of Tris-Buffer 3 (FPLC 
Fractions 6, 7, 8 & 9. These were combined into two dialysis bags, (a) - Fractions 6 & 7 
and (b) - Fraction 7 & 8). This allows the resolvase to refold in solution. The two 
solutions of resolvase (a) and (b) were dialysed for the second time against “low salt”
Figure 5.6 D102Y Resolvase purification - Gel 1
Illustration of resolvase purification up to the denaturing step. See text for 
details.
Lanes 1 - Resuspended induced cells (IS)
2 - Supernatant after sonication and precipitation (2S)
3 - Pelleted sonicated cells (2P)
4 - Supernatant from first wash (3S)
5 - Pelleted cell debris (3P)
6 - Supernatant from second wash (4S)
7 - Pelleted cell debris (4P)
8 - Cell debris resuspended in 7 M urea (5S)
9 - Pelleted cell debris (5P)
4
Figure 5.7 D102Y Resolvase purification - Gel 2
Continuation of the resolvase purification. Fractionation on the SP sepharose 
Fast Flow column. See text for details.
Lanes 1 - Column flow-through
2 - Column wash
3 - Fraction 1
4 - Fraction 2
5 - Fraction 3
6 - Fraction 4
7 - Fraction 5
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these at 15 000 rpm, 4 °C, 10 minutes it was redissolved, in a small volume of RHB (100 
(il) giving Sn (a) and (b). These were run on a Laemmli gel to determine their 
concentration and purity (Figure 5.8). Staining with Coomassie did not reveal any 
contaminating protein bands.
Purified resolvase was then stored in RHB + 50% v/v glycerol at -20 °C. Considering 
the dramatic improvement in the over expression of resolvase with the new pET based 
expression system, the yields from the new purification protocol, though reproducible 
and consistent, have been relatively low. On examination of the Laemmli gels run 
concurrent with the purification, it was observed that at several stages the resolvase 
concentration drops visibly. The first of these is the resuspension of the pellet in Urea 
Buffer for the first time. Though it is difficult to measure accurately the proportion of the 
pellet run on the gel, it is obvious that there is a substantial amount of resolvase which 
remains in the pellet at this time. The second stage where resolvase disappears is during 
separation of the urea solution down the small SP Sepharose column. On loading, it 
seems that not all the resolvase is bound to the column, and some may be lost as flow 
through. However this does not account for the large loss of resolvase. There is little 
evidence of degradation of the protein at this time. The final stage where resolvase is lost 
is at the end of the purification where the protein has been dialysed and is redissolved in 
storage buffer. It is difficult at this stage to resuspend all the resolvase.
Nevertheless, the new procedure seems to be very reproducible, and resolvase has been 
purified successfully from all mutants tried so far. Wild-type resolvase was purified in 
this manner from pTAl, a precursor to pSAl 101. In standard resolution assays, 
resolvases produced by this new denaturing method have been shown to be comparable 
in activity to resolvase previously prepared using a non-denaturing method.
The following mutant resolvases were made by this procedure in vitro', L69F, D102Y, 
and E124Q. The expression plasmids pATXD102Y and PATXL69F were created by 
removing the (Asp!IS - Ndel) restriction fragment, containing the resolvase reading 
frame from pAT5D102Y and pAT4 respectively, and replacing the equivalent fragment in 
pSAl 101. The creation of pATXE124Q is described in Chapter 4. Y6F resolvase was 
made by a similar purification protocol, but using the pKK223-based expression system
Figure 5.8 Resolvase purification Gels 3 & 4
Gels illustrating D102Y resolvase purification by monoS FPLC and 
showing its final purity after dialysis. Lanes 2-10 comprise fractions taken 
from the FPLC column. Lanes 11-13 show resolvase after the dialysis steps.
Lanes 1 - Resolvase marker
2 - FPLC Fraction 1
3 - FPLC Fraction 2
4 - FPLC Fraction 3
5 - FPLC Fraction 4
6 - FPLC Fraction 5
7 - FPLC Fraction 6
8 - FPLC Fraction 7
9 - FPLC Fraction 8
10 - FPLC Fraction 9
11 - Sn (a) after Dialysis
12 - Sn (b) after Dialysis
13 - Resolvase marker
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(see Chapter 3). The EcoRl - HindBl fragment of pKK223 was replaced by the 
equivalent fragment of pDB6020-Y6F to give the expression plasmid pATXY6F.
5.4 Summary
This chapter has outlined a new expression and purification protocol for T ni resolvase. 
The expression system utilises the pET plasmid system to greatly increase the levels of 
resolvase expressed per gram of cells. The purification system which has been developed 
is a denaturing protocol, and it has been shown to be reproducible for the variety of  
mutants which have been created (see Chapter 4; A. McDonald, personal 
communication).
Chapter 6
In vitro analysis o f altered Tn3 resolvases
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In Vitro Analysis of altered Tn3 Resolvases
6.1 Introduction
After the construction and subsequent purification of a selection of Tni resolvase 
mutants, (see Chapters 4 and 5) it was now possible to examine their behaviour in vitro. 
Investigation of their in vivo properties, using the galK screen (see Section 4.5) indicated 
that the mutant Y6F was catalytically inactive in the wild type reaction, E124Q and L69F 
showed behaviour typical of the wild type protein, and D102Y in addition to promoting 
the wild type reaction in vivo, could catalyse recombination on a substrate containing one 
complete res site and an incomplete site consisting only of site I (see Chapter 5). 
Examination of in vitro products by agarose gel electrophoresis can provide us with more 
detailed information as to how the reaction is proceeding as compared to the in vivo 
results. These indicate only whether the recombination reaction has taken place.
Analysis in vitro may help to determine the relative efficiencies of the reactions of 
mutants, and if illegitimate reactions, such as intermolecular recombination and cleavage 
events, are taking place which may not be detected in in vivo assays. In vitro analysis is 
also important in determining the topology of the reaction products formed.
The standard resolvase in vitro reaction system is described in Section 2.33. A substrate 
plasmid containing two res sites in direct repeat is treated with dilutions of TnJ resolvase 
in an appropriate buffer. Resolution of the substrate by wild type resolvase results in the 
formation of a singly linked catenane; after restriction digestion with an appropriate 
enzyme that cuts at only one site in the substrate, a linear piece of DNA and a circle are 
produced. The reaction is illustrated in Figure 3.1. By using a variety of substrate 
plasmids containing partial or complete res sites, the properties of the mutant proteins can 
be determined in vitro.
The substrates used for analysis of the mutants are detailed in Figure 6.1. These 
substrates, except for the wild type substrate pMA21 containing two res sites in direct 
repeat, contain a variety of partial and whole res sites which would not be resolved by the 
wild type protein under the standard conditions. The standard conditions for the 
resolution reaction include incubation at 37 °C for a period of 30 minutes, in the standard
res J
(2.3 kb)
pMA21 
4.9 kb
Pst I
(2.6 kb)
ori
res ±
XZ.3 kb)pMA2631 
4.9 kb
Pst I
(2.6 kb)
ori
res
site I ^
site I ^
(2.39 kb)pAL265 
4.8 kb
Pst pAL225 
4.9 kb
XZA5  kb)Pst I
(2.46 kb) (2.45 kb)
ori
orires
site I
Figure 6.1 In vitro Tn3 resolvase substrates
Diagrams of the plasmid substrates used for in vitro 
analysis of resolvase recombination. Sizes indicated in brackets 
refer to the resolution products of the substrate.
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reaction buffer, C9.4 (50 mM Tris-HCl (pH 9.4), 10 mM MgCl2, 0.1 mM EDTA) with 
an aliquot of resolvase (see Section 2.33).
The other technique used in this chapter to analyse the properties of mutant proteins is the 
band shift assay. This allows us to examine the early steps in the reaction, whether the 
protein is binding to the res site as the wild type protein would, by forming the standard 
six complexes when bound to a linear full length res site. In this assay, the wild-type 
protein has been shown to bind as a monomer in a co-operative manner (Blake, 1993; 
Blake et al., 1995). The plasmid used to generate the res fragment to which the resolvase 
is bound in the assay is illustrated in Figure 6.2.
6.2 In vitro analysis of Y6F Resolvase
After purification of the Y6F mutant, resolvase recombination activity in vitro was 
determined in the standard resolution assay (see Section 2.33).
In order to carry out a titration of the Y6F protein, a series of 2 fold dilutions of the stock 
solution was carried out. In the case of Y6F, it had been predicted that the protein would 
have little or no recombinational activity; therefore reactions were carried out for various 
lengths of time on a wild type substrate, pMA21 (containing 2 directly repeated res sites; 
Figure 6.1). The reaction was carried out in C8 buffer (defined in Section 2.33). 40 pi 
samples were incubated at 37 °C, after which the resolvase was inactivated by heat (70 
°C for 5 minutes). 20 pi was then removed, and a HindJll restriction digest was carried 
out. Since there is only one site for HindlQ on the substrate plasmid pMA21, the enzyme 
cleaves only one of the circles in the catenane product, resulting in a linear piece of DNA 
and a small free circle; these products can be distinguished from the original substrate by 
agarose gel electrophoresis.
Agarose gel electrophoresis (Figure 6.3) showed that the Y6F protein was completely 
inactive, which may be expected since we have mutated a highly conserved residue. 
However, the Y6F protein did retain some topoisomerase activity, and slowly relaxed the 
substrate DNA. This suggests that the protein has retained its ability to bind to the 
substrate, cleave, relax and religate the DNA, but is unable to complete the recombination
2639 bp
Figure 6.2 Illustration of pOG5
The diagram shows the plasmid used in the generation of the fragment 
used for gel shift assays. The fragment was created by an Xbal - A sp llS  
restriction digest. pOG5 is derived from pMTL23. The res in pOG5 has 
been altered from the wild-type at 3 bp between sites I and II, creating an 
FcoRI site (Blake et al., 1995).
1 2 3 4 5 6 7 8 9 10 11 12 13
Nicked substrate 
Linear substrate
Supercoiledsubstrate 
Linearised circle (product)
Free circle (product)
Figure 6.3 Reaction of pMA21 with the Y6F mutant of Tn3 resolvase
Reaction of pMA21 was carried out in C8 buffer for 16 hours at 37 °C.
After heat inactivation at 70 °C, a H indlll restriction digest was carried out
on half the reaction mix (20 pi). Restricted and unrestricted samples were 
loaded onto a 1.2% agarose gel , which was run at 40 V for 14 h. A series of 2- 
fold dilutions of Y6F resolvase were used. The approximate stock concentrations of 
Y6F resolvase and wild-type resolvase are 12 pM and 400 pM respectivley.
Lanes 1 - 1 kbp ladder
2 - undiluted Y6F
3 - 2-fold dilution of Y6F
4 - 4-fold dilution of Y6F 
5 -8-fold dilution of Y6F
6 - No resolvase control
7 - 8-fold dilution of wild-type resolvase
8 - 13 - As samples 2 - 7 ,  but digested with H indlll.
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recombination reaction. This evidence suggests that the tyrosine-6 is not required as a 
nucleophile for the cleavage and religation of the DNA to proceed. But, it must have 
some important role, perhaps as a proton donor/acceptor, or in the structure of the active 
site. Topoisomerisation is observed but not recombination, perhaps because it requires 
the cleavage of only one DNA phosphodiester, whereas recombination requires 
simultaneous cleavage of four phosphodiesters.
Two further experiments were carried out to determine the effect of the Y6F mutation on 
the recombination reaction. A dilution of wild type resolvase, which promoted 
recombination at a very low level, was added to a series of Y6F dilutions, and 40 |xl 
reactions were incubated for 30 minutes as above. The reactions were stopped, and 20 (il 
from each sample was treated with Hind HI. As Figure 6.4 shows, the presence of an 
increasing amount of Y6F protein does not seem to increase the rate or level of 
recombination taking place, but topoisomerase activity on the substrate is seen at the 
higher concentrations of Y6F. Note that this topoisomerase activity is much higher than 
with Y6F alone, as in Figure 6.3 (incubation was for only 30 min rather than 16 h). 
Equally, an experiment carried out where a Y6F dilution was added to the standard 
resolvase reaction, carried out in the same way as above (Figure 6.5) showed an 
enhancement of the topoisomerase activity shown previously by the protein, on the 
substrate as well as the product. This addition of the wild-type protein resulting in an 
enhancement of topoisomerase activity, followed by recombination suggests that the 
replacement of increasing numbers of subunits of the Y6F protein by wild-type resolvase 
at site I, allows the protein at site I to catalyse the recombination reaction. The possibility 
has not been ruled out that Y6F resolvase is completely catalytically inactive, and the very 
weak topoisomerase activity of the Y6F preparation is caused by traces of wild-type 
resolvase in it (for example, by accidental incorporation of tyrosine instead of 
phenylalanine during translation of the mRNA). Topoisomerase activity, seemingly 
induced here by the addition of wild-type resolvase, has been observed in experiments 
using wild-type resolvase when some defect in the system interferes with normal 
recombination, such as inappropriately spaced or mutant res sites (Stark et al., 1991). 
This would suggest that the catalytic inactivity of the Y6F protein is not due to the 
disruption of the synaptosome by the mutation, since the protein may still be bound to the 
accessory sites, but is due to the modification of the enzyme at the active site. Further
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
^  Nicked substrate 
^  Linear substrate
^  Supercoiled substrate
^  Linearised circle 
(product)
Free circle (product)
Figure 6.4 Effect of increasing amounts of Y6F resolvase on the wild-type 
reaction
Resolution reactions of pMA21 with wild-type resolvase (diluted to give only 
a low level of resolution) and increasing amounts of Y6F resolvase. Reactions 
were incubated for 30 minutes at 37 °C before stopping, and a restriction digest 
was carried out with Hindlll on half the reaction mixture. Both restricted and 
unrestricted samples were loaded on a 1.2% agarose gel and run at 40 V 
overnight. The approximate protein concentration of stock Y6F resolvase is 12 
pM, while stock wild-type resolvase is approximatly 400jiM.
Lanes 1 - Undiluted Y6F resolvse
2 - Undiluted Y6F resolvase + wild-type resolvase
3 - 2-fold dilution of Y6F resolvase + wild-type resolvase
4 - 4-fold dilution of Y6F resolvase + wild-type resolvase
5 - 8-fold dilution of Y6F resolvase + wild-type resolvase
6 - 16-fold dilution of Y6F resolvase + wild-type resolvase
7 - 32-fold dilution of Y6F resolvase + wild-type resolvase
8 - Wild-type resolvase alone
9 - No resolvase control (dilution buffer)
10 - 18 - Samples from lanes (2) to (9) restricted with Hindlll.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
(Nicked substrate 
(Linear substrate
(Supercoiled substrate
(Linearised circle 
(product)
(Free circle (product)
Figure 6.5 Effect of adding increasing amounts of wild-type resolvase to Y6F 
reactions
Reactions with wild-type resolvase and a 4-fold dilution of Y6F 
resolvase were incubated at 37 °C for 30 minutes then stopped by heat. 
Half the reaction mix was removed and a H indlll digest was carried out. 
The restricted and unrestricted samples were loaded onto a 1.2% agarose 
gel and run at 40 V. Approximate protein concentrations are as indicated 
in Figure 6.3.
Lanes 1 - 1 6  -fold dilution of wild-type resolvase
2 - 1 6  -fold dilution of wild-type resolvase + Y6F resolvase 
3 - 32 -fold dilution of wild-type resolvase + Y6F resolvase
4 - 6 4  -fold dilution of wild-type resolvase + Y6F resolvase
5 - 1 2 8  -fold dilution of wild-type resolvase + Y6F resolvase 
6 - 256 -fold dilution of wild-type resolvase + Y6F resolvase 
7 - 5 1 2  -fold dilution of wild-type resolvase + Y6F resolvase
8 - 4-fold dilution of Y6F resolvase
9 - No resolvase control (dilution buffer)
10 - 18 - As lanes 2 - 1 0  but restricted with H indlll
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evidence to support this comes from the y8 Y6F protein (Leschziner et a l , 1995). 
Experiments in which y8 Y6F resolvase was targeted to the accessory sites, and using a 
mutated site I, which bound only a specific mutant able to carry out catalysis, resulted in 
normal products, indicating that the synaptosome was stable when the Y6F protein was 
bound at sites II and ID. The y8 Y6F protein was also found to be recombinationally 
inactive, but retained the ability to promote cleavage and religation, displayed by the 
observation of topoisomerase activity.
Binding studies confirmed that in the presence of a linear res site, the protein forms the 
standard 6 complexes. (Figure 6.6). The protein shows no obvious differences in its 
binding pattern in comparison to the wild type protein. This indicated that the defect in 
Y6F does not inhibit the binding of the protein, and so Y6 must play a role in a 
subsequent step in the reaction. Though it is not clear yet as to the precise role of 
tyrosine-6 in the reaction, the results have shown it is important for catalysis.
6.3 Analysis of E124Q Resolvase
From in vivo studies on the E124Q protein (Chapter 5), it was predicted that this protein 
would retain wild-type recombinational activity, but unlike the yS E124Q resolvase 
mutant would have little or no activity on partial res sites.
It had been predicted from the co-crystal structure of yS resolvase bound to site I (Yang 
and Steitz, 1995) that E124 was important since it formed a hydrogen bond with serine- 
10 of one of the subunits. This hydrogen bond was thought to be helping to hold the 
protein in an inactive configuration. E124 mutants may therefore be “activated” in that a 
mutation may remove the hydrogen bonding and allow the structure more flexibility. 
This was found to be the case with the y8 E124Q mutant, which was observed to carry 
out recombination reactions on linear substrates and partial res sites, catalyse 
intermolecular reactions and to sometimes leave cleaved ends. These are all events not 
normally catalysed by the wild-type protein. The y8 E124Q mutant has what can be 
described as a hyperactive phenotype in comparison to the wild-type protein.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
unboundI
u
■ I—mmu|
Figure 6.6 Binding of wild-type, L69F and Y6F resolvases to res
2 fold dilutions of each protein were used to carry out a titration on the res 
fragment. The approximate concentrations of the protein stocks are as 
follows,
Wild-type resolvase - 400 |iM 
L69F resolvase - 50 pM 
Y6F resolvase - 12 (iM
Lanes 1 - 16-fold dilution of wild type resolvase
2 - 32-fold dilution of wild type resolvase
3 - 64-fold dilution of wild type resolvase
4 - 128-fold dilution of wild type resolvase
5 - No resolvase (dilution buffer)
6 - Undiluted L69F resolvase
7 - 2-fold dilution of L69F resolvase
8 - 4-fold dilution of L69F resolvase
9 - 8-fold dilution of L69F resolvase
10 - No resolvase (dilution buffer)
11 - Undiluted Y6F resolvase
12 - 2-fold dilution of Y6F resolvase
13 - 4-fold dilution of Y6F resolvase
14 - 8-fold dilution of Y6F resolvase
15 - No resolvase (dilution buffer).
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Initial studies confirmed that the Tn3 resolvase mutant E124Q was active on the wild-type 
substrate pMA21 (Figure 6.7). Restriction digests of the reaction with an enzyme which 
cleaves the substrate DNA once, results in the linear and circular products one would 
expect from the wild-type reaction; however, the circular product has been relaxed to a 
relatively high extent. This topoisomerase activity may suggest that the E124Q mutant 
has enhanced cleavage activity, or has lost the specificity for formation of the 
synaptosome before cleaving the DNA, possibly due to its “activation”. The agarose gel 
of the undigested resolution reactions indicates the mutant E124Q is displaying behaviour 
unlike that of the wild-type protein. A variety of cleavage products, including linear and 
circular molecules are seen on the gel. A large proportion of the circular products are 
nicked. Bands corresponding to nicked recombinant circles and half-nicked catenane are 
observed. These are indications that the mutant has an activated phenotype whereby it will 
cleave the DNA without the full recombination reaction taking place. The presence of 
double strand cleavage products also indicates that the complete recombination reaction 
did not take place. This mutant does not seem to have as activated a phenotype as the y5 
E124Q mutant, but compared to wild-type Tn3 resolvase, this mutant gives enhanced 
cleavage of substrate and products.
No recombinational activity on plasmids containing partial res sites (pAL265 and 
pAL225) by T ni E124Q resolvase was observed. Various conditions were explored, 
including changing length of incubation and the buffer conditions, but to no avail (data 
not shown). This is contrary to the y8 E124Q resolvase which had the ability to carry out 
recombination on partial res sites in vitro (M. Boocock, personal communication).
In band shift assays (Figure 6.8), E124Q resolvase displayed a slightly different than 
normal binding pattern. The protein has the ability to form the lower complexes, and 
seems especially efficient at forming the first complex (corresponding to binding of a 
resolvase monomer), but seems to find it difficult to form the higher complexes such as 
the fifth and sixth. This would indicate less efficient binding than normal. This 
inefficiency in binding may lead to some of the altered behaviour observed in the in vitro 
analysis; for example, the double strand cleavage products might be the result of 
premature dissociation of resolvase subunits in a recombination intermediate.
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Figure 6.7 Resolution of pMA21 (res v res) by E124Q resolvase
Resolution reactions were incubated with dilutions of E124Q resolvase 
for 1 h in C8 buffer, then stopped with heat and half the reaction mix 
was digested with Pstl. Samples were run on a 1.2% agarose gel for 
16 h at 40 V. Of the four cleavage and nicking product bands, two 
correspond to nicked products (the top and third bands) and two 
represent linearised circles cleaved at res (the second and fourth 
bands). The approximate concentration of E l24 stock resolvase is 50 
pM.
Lanes 1 - 1 kbp ladder
2 - Undiluted E124Q resolvase
3 - 2-fold dilution of E124Q resolvase
4 - 4-fold dilution of E124Q resolvase
5 - No resolvase control (dilution buffer)
6 - Undiluted E124Q resolvase; digested with Pstl
7 - 2-fold dilution of E124Q resolvase; digested with Pstl
8 - 4-fold dilution of E124Q resolvase; digested with Pstl
9 - No resolvase control (dilution buffer); digested with Pstl
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
unbound
Figure 6.8 Binding of wild-type, D102Y and E124Q resolvases to res
2 fold dilutions of each protein were used to carry out a titration on the res 
fragment.The approximate protein concentrations of resolvase stocks are 
as follows,
Wild-type resolvase - 400 pM 
D102Y resolvase - 100 pM 
E124Q resolvase - 50 pM
Lanes 1 - 16-fold dilution of wild-type resolvase
2 - 32-fold dilution of wild-type resolvase
3 - 64-fold dilution of wild-type resolvase
4 - 128-fold dilution of wild-type resolvase
5 - No resolvase (dilution buffer)
6 - Undiluted D102Y resolvase
7 - 2-fold dilution of D102Y resolvase
8 - 4-fold dilution of D102Y resolvase
9 - 8-fold dilution of D102Y resolvase
10 - No resolvase (dilution buffer)
11 - Undiluted E124Q resolvase
12 - 2-fold dilution of E124Q resolvase
13 - 4-fold dilution of E124Q resolvase
14 - 8-fold dilution of E124Q resolvase
15 - No resolvase (dilution buffer)
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6.4 Analysis o f L69F resolvase
Since we had inadvertently made this protein, we observed its in vitro properties. Since 
the first in vivo screening experiments were carried out using pAT4 (L69F), it was 
important to show that its phenotype had not been compromised. L69 is close to the 
active site of the protein (Chapter 3) and is quite well conserved throughout the Tni 
resolvase family. However, the change from leucine to phenylalanine is a fairly 
conservative change, both amino acids being hydrophobic in nature. Replacement of 
leucine with a hydrophilic or charged residue at position 69 might have resulted in a more 
drastic outcome. In vivo screening of L69F (pAT4) showed that the protein was able to 
catalyse the wild-type reaction, but had no activity on plasmids containing partial res sites 
(data not shown).
An in vitro resolution reaction confirmed the ability of the L69F protein to perform 
resolution on the wild-type substrate, pMA21 (Figure 6.9). The protein also 
demonstrated a higher than normal level of topoisomerase activity, indicating that the 
mutation at L69 was having some effect on the activity of the protein, as previously seen 
with wild-type resolvase when a defect in the system prevents normal recombination 
(Stark et al., 1991). Resolution reactions carried out on pAL265 and pAL225 confirmed 
the inability of the protein to promote resolution between partial res sites (data not 
shown).
The gel shift assay shown in Figure 6.6 demonstrated that this protein is more efficient at 
forming the higher fifth and sixth complexes in comparison with the wild-type protein. 
This aberration in binding activity may account for some of the unusual in vitro properties 
of the protein.
6.5 Analysis of D102Y resolvase
From the in vivo studies, the most likely of the mutants to carry out recombination in 
vitro on partial res sites was the “selected” mutant D102Y. This mutant demonstrated the 
ability to carry out resolution on a substrate plasmid containing one complete res site in 
direct repeat with a single site I, in vivo. However, the in vivo screen operates on the
1 2 3 4 5 6 7 8 9  10 11 12 13 14 15 16 17 18 19 20
I Nicked substrate 
f Linear substrate
I Supercoiled substrate 
1 Linearised circle 
(product)
I Free circle (product)
Figure 6.9 Resolution of pMA21 by L69F resolvase
Wild-type and L69F resolvase reactions were carried out in C9.4 buffer for 
30 minutes before digesting half the reaction mix with Pstl. Samples were 
run on an agarose gel (1.2%) for 14 hours at 40 V. The approximate 
concentration of L69F stock resolvase is 50 |iM , while wild-type resolvase 
stock concentration is 400 )liM.
Lanes 1 - 4-fold dilution of wild-type resolvase
2 - 8-fold dilution of wild-type resolvase
3 - 16-fold dilution of wild-type resolvase
4 - 32-fold dilution of wild-type resolvase
5 - 64-fold dilution of wild-type resolvase 
6 -10 - As lanes 1 - 5 ,  but restricted with Pstl
11 - Undiluted L69F resolvase
12 - 2-fold dilution of L69F resolvase
13 - 4-fold dilution of L69F resolvase
14 - 8-fold dilution of L69F resolvase
15 - No resolvase control (dilution buffer)
16 - 20 - As lanes 11 - 15, restricted with Pstl
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basis that very little resolvase is required in order to resolve the low copy number plasmid 
and result in a ga l clone, that is, a white colony on MacConkey galactose medium. This 
was not necessarily an indication that the protein would promote the reaction sufficiently 
to demonstrate the same result in vitro, or if indeed the reaction did proceed, to give 
sufficient reaction to allow analysis of the topology of the resulting products. It was also 
possible that the resolvase protein containing the D102Y mutation could perform partial 
resolution of the site I v site I plasmid which may be undetected in vivo, but observed in 
vitro.
Resolution reactions carried out with the wild type substrate, pMA21, in a variety of 
buffers showed that D102Y performed the standard resolution reaction as well as a 
variety of intermolecular reactions not normally observed to be carried out by the wild- 
type resolvase protein. (Figure 6.11). The products of a reaction using the buffer, 
M15M8 (see Section 2.33), for an incubation period of 6 h are shown in Figure 6.10.
The protein clearly displays topoisomerase activity, relaxing the substrate DNA. Some 
free circular cleavage products and linear DNA are observed; however, these products are 
not formed to the same range or extent as the cleavage products from the action of the 
mutant protein E124Q on the substrate, pMA21, indicating that D102Y is relatively well 
behaved regarding the rejoining of the DNA ends. The protein clearly demonstrated a 
relaxed specificity for the substrate since it performed resolution between sites on 
different plasmids, indicated by the presence on the gel of bands ranging from 6 to 8 kb. 
Such intermolecular reactions are illustrated in Figure 6.11. These bands correspond to 
reactions between res sites present on different supercoiled substrates where the ends are 
joined as in the wild-type reaction, the left half of one site to the right half of the second. 
Bands present also indicate that certain “illegitimate” recombination events are taking 
place, where the right end of one res site is joined to the right end of the second res site 
on the other substrate molecule and left to left. This result is in keeping with the results 
of resolution reactions carried out on the substrate pAL265 (res v site I) (see below) and 
indicates that the protein is acting, to some degree, independently of the accessory sites II 
and IH, unlike the wild-type protein.
Resolution reactions carried out on pAL265 (res v site I) at 37 °C for 16 hours in C9.4 
buffer, showed that in vitro D102Y resolvase was able to resolve this plasmid. On
Nicked substrate 
Linear substrate
Inter­
molecular
products
Supercoiled substrate 
Linearised circle 
(product)
Supercoiled circle (product)
Figure 6.10 Resolution of pMA21 (res v res) by D102Y resolvase
Resolution reactions were carried out in M15M8 buffer for 6 h at 37 °C, and 
subsequently half the reaction mix was digested with Pstl. Samples were run on 
an agarose gel at 40 V for 16 hours. The gel clearly shows many products which 
have been accounted for as products of cleavage reactions, and the intermolecular 
reactions illustrated in Figure 6.11. The approximate concentration of stock 
D102Y resolvase is 100 |iM, while the approximate concentration of wild-type 
resolvase stock is 400 (J.M.
Lanes 1 - 1 kbp ladder
2 - Undiluted D102Y resolvase
3 - 2-fold dilution of D102Y resolvase
4 - 4-fold dilution of D102Y resolvase
5 - 8-fold dilution of D102Y resolvase
6 - No resolvase control (dilution buffer)
7 - 16-fold dilution of wild-type resolvase
8 - No resolvase control (dilution buffer)
9 - 15 - As lanes 2 - 8 ,  digested with Pstl
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examination of the agarose gel (Figure 6.12), the Pstl digest showed that the products 
were as expected, a free circle and a linear length of DNA. The protein is relatively poor 
at promoting the reaction, which proceeds at about 20%; but this is a dramatic 
improvement on the ability of the wild-type protein to promote this reaction under these 
conditions. This shows the ability of the protein to carry out the reaction in the absence 
of the accessory sites II and ID on at least one of the res sites present in the substrate.
The reaction is however proceeding through the standard pathway resulting in the 
catenane product (Figure 6.13), showing that even in the absence of these accessory sites 
the protein is bringing the sites together to form the normal synapse. However, D102Y 
resolvase was completely unable to perform any observable recombination on the site I v 
site I substrate, pAL225. It also failed to show any recombinational activity on the 
plasmid pAL2631, which contains inverted res sites. These results show that although 
D102Y resolvase has lost some of its dependency on the accessory sites, it is not totally 
independent of their presence, and still prefers to carry out the wild-type reaction, 
recombining two res sites in direct repeat.
Binding studies (Figure 6.8) showed that the protein displayed a normal binding pattern, 
indicating that its enhanced activity was not due to any greater affinity of the protein for 
the DNA.
Summary
The in vivo results on the four mutant resolvases investigated have been upheld by the in 
vitro analysis, which has also expanded our knowledge of the reactions taking place. 
Y6F resolvase has been confirmed as being recombinationally inactive, but has been 
shown to retain its binding ability as well as cleavage and religation activity. Though 
studies of topoisomerases and strand transferases have shown the catalytic breakage and 
rejoining of DNA via transesterifications using phosphotyrosyl linkages, the evidence 
here supports the linkage, in the case of Tni resolvase as being a phosphoseryl (serine- 
10). L69F resolvase has been shown to resolve the wild type substrate pMA21, but has 
also demonstrated some topoisomerase activity as well as aberrations in binding. Unlike 
the y5 E124Q resolvase mutant, the equivalent Tn3 resolvase E124Q mutant has not 
shown the ability to resolve partial res sites, but can perform intermolecular reactions.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
^  Supercoiled 
circle 
(product)
^  Supercoiled substrate 
Linearised 
circle(product)
Nicked substrate 
Linear substrate
Figure 6.12 Resolution of pAL265 {res v site I) by D102Y resolvase
Resolution reactions were carried out in C9.4 buffer for 30 minutes, and half 
the mixture was digested with Pstl. Samples were run on a 1.2% agarose gel 
at 40 V for 16 hours. The approximate concentrations of D102Y resolvase 
and wild-type resolvase stocks are as indicated in Figure 6.10.
Lanes 1 - 1 kbp ladder
2 - Undiluted D102Y resolvase
3 - 2-fold dilution of D102Y resolvase
4 - 4-fold dilution of D102Y resolvase
5 - 8-fold dilution of D102Y resolvase
6 - No resolvase control (dilution buffer)
7 - 2-fold dilution of wild-type resolvase
8 - No resolvase control (dilution buffer)
9 - Undiluted D102Y resolvase on pMA21 (wild-type control
substrate)
10 - No resolvase control, with pMA21 (dilution buffer)
11 - 19 - As lanes 1 - 9, digested with Pstl
1 2 3 4 5 6
P P P iHjj
g g Al
7 8 9 10 11 12
Nicked substrate
Supercoiled substrate 
(-2) catenane
Linear substrate
Linear
products
Supercoiled
circle
(product)
13 14 15 16 17 18
-^N icked  substrate 
^ L in e a r  substrate 
^ ( - 2 )  catenane
Figure 6.13 Comparison of activity of wild-type and D102Y resolvases
The figure compares the DNase I nicking reactions of wild-type resolvase and 
D102Y resolvase on the wild-type substrate pMA21. Also shown is the 
nicking reaction of D102Y on the plasmid pAL265 (res v site I) indicating the 
presence of the (-2) catenane as the major product of the reaction. 60 |il 
resolution reactions were carried out for 1 h at 37 °C then stopped with heat.
One third of each mixture was removed and digested with Pstl and one third was 
nicked with DNasel. All samples were run on a 1.0 % agarose gel for 16 h at 
40 V. The approximate concentrations of the stock resolvase solutions are as 
indicated in Figure 6.10.
Lanes 1 - Undiluted D102Y resolvase / pMA21
2 - 16-fold dilution of wild-type resolvase / pMA21
3 - No resolvase control (dilution buffer) / pMA21
4 - Undiluted D102Y resolvase / pAL265
5 - 6-fold dilution of wild-type resolvase / pAL265
6 - No resolvase control (dilution buffer) / pAL265 
7 - 9 - As 1 - 3, digested with Pstl
10 - 12 - As 4 - 6  digested with Pstl 
13 - 15 - As 1 - 3. treated with DNase I 
16 - 18 - As 4 - 6  treated with DNase I.
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D102Y, the mutant isolated by the in vivo screen as performing resolution on a substrate 
with site I v res, was shown to perform the same reaction in vitro, as well as 
intermolecular reactions. Its binding pattern indicates that this activity is not due to 
enhanced binding.
Chapter 7
Discussion
80
D iscussion  
7.1 General remarks
The first Tni resol vase mutants have been isolated, using the plasmids pAT4 and pAT5, 
developed for the purposes of mutagenesis and compatible with an in vivo galK  screen 
(see Section 3.1). Two specific mutants were created by site-directed mutagenesis, Y6F 
and E124Q; a third, L69F, was made inadvertently (Figure 7.1). All the mutants were 
tested for their activities in vivo. Random mutagenesis of the E-helix of Tni resol vase 
did not produce the long awaited mutant able to catalyse recombination between two site 
I s. However a mutant, D102Y, was isolated with the ability to catalyse resolution 
between res v site I {in vivo). In order to analyse these proteins in vitro, a new 
denaturing purification system was developed, now shown to be reproducible for a range 
of Tn3 resolvase mutants. Greater yields of resol vase were achieved by employing a new 
expression vector, with resolvase transcription from a T7 RNA polymerase promoter. 
Subsequent analysis has determined the in vitro properties of the mutant resolvases.
7.2 Analysis of resolvase point mutants
A number of catalytically active and inactive mutants were isolated during screening of the 
mutant libraries created (Chapter 4; Figure 4.6). On closer examination, a number of 
observations can be made. These mutations are highlighted in Figure 7.2.
Catalytically active Tn3 resolvase mutants ("white" colonies) in general are relatively 
conserved changes of the surface residues e.g. G96A, S98C, T99S, D102E and SI 12C. 
The minor changes apparently do not disrupt the E-helix, leaving the catalytic activity of 
resolvase unaffected.
Figure 7.3 shows sequence alignment of some related proteins. These include the Gin, 
Cin and Hin invertases and Tn2i. The alignment shows the most conservative residues 
in this region, the E-helix, as El 18, R119 and E l24.
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Figure 7.2 Point Mutations
Diagram illustrating the positions of the point mutations isolated 
from the mutant libraries. These mutants are also represented in 
Figure 4.7. The positions where catalytically inactive mutants were 
found are shown in red, while catalytically active mutants are 
displayed in white. The positions at which both inactive and active 
mutants were isolated are illustrated in pink.
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Analysis of the catalytically inactive mutants ("red" colonies) is perhaps more complex. 
The methionine at position 106 has a relatively long slender hydrophobic side-chain, 
pointing inwards to the 1,2 dimer interface. Mutation of this residue to valine introduces 
a short bulky side-chain, as does the threonine mutation (also red/dead) which in addition 
is less hydrophobic. It is not surprising since these mutants disrupt the packing of the E- 
helix and are recombinationally inactive.
Mutation of threonine at position 99 to proline yields a catalytically dead mutant. Proline 
does not fold into sheets and so may disrupt the configuration of the loop between the D 
and E-helices (the D-E loop).
At first glance, the mutation at position 118 from glutamate to glutamine seems very mild 
and it is surprising that this renders resolvase inactive. However, position 118 is almost 
100% conserved throughout the family (Figure 7.3). This conservation indicates that 
even mild changes at this position cannot be tolerated. The inactivity of the mutant 
containing glycine at this position is more readily explained since the introduction of a 
short side-chain may disrupt and possibly break the helix.
Both "red" and "white" mutants have been found at position 112. Mutating this serine to 
a cysteine results in a catalytically active protein. However mutation to a tyrosine kills the 
recombinational activity. Serine is a hydrophilic residue, its mutation to a hydrophobic 
tyrosine, may disrupt the helix, being counter to the amphipathicity of the E-helix.
7.3 Analysis of D102Y resolvase
Though the random mutagenesis carried out did not produce a Tn3 resolvase mutant with 
the ability to catalyse in vitro reaction between two site I’s, the isolation of the mutant 
D102Y, which had the ability to catalyse recombination in vitro and in vivo on a plasmid 
containing only site I v res, is definitely informative, and a step towards the eventual 
isolation of a mutant recombinationally independent of sites II and m.
So, how does the change from aspartate to tyrosine at this position influence the ability of 
the protein to carry out this reaction?
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Position 102 is not strictly part of the E-helix observed in the crystal structures of y5 
resolvase; it is at the very top end of the E-helix, and the residue of resolvase which is 
furthest from the DNA in the co-crystal structure. It is not present on any known 
interface between subunits, either in the crystals or in solution. The co-crystal structure 
of y8 resolvase bound at site I (Yang and Steitz, 1995) shows residue 102 on one subunit 
pointing outward into space, while the second points inward to the helix (Figure 7.4). In 
y8 resolvase residue 102 is a glutamate, and on the residue pointing inward is making an 
ionic interaction with the lysine at position 105 (Figure 7.5). This residue is glutamine in 
Tn5 resolvase, and so it seems unlikely that there will be an equivalent aspartate- 
glutamine interaction. D 102 is not a well conserved residue, being glutamate in y8 
resolvase and Tn27, leucine in Bin3, and alanine in Tn4451 resolvase (Figure 7.3) The 
nature of the sidechain at position 102 could be important for some control feature of the 
reaction, regulating recombination.
Substitution of tyrosine for aspartate at position 102 in the Tni mutant resolvase may 
have caused a conformational change, by altering the secondary structure of this region of 
the protein. A model for strand exchange proposed after analysis of the recent co-crystal 
structure and taking into account features of this structure, has suggested the possibility 
that the loop around this position between the bottom of the E-helix and the N-terminal 
domain, is flexible. This model has been named "catalytic domain rotation" and is 
illustrated in Figure 1.9. It is proposed that the loop acts as a flexible hinge, allowing the 
illustrated movement of the catalytic N-terminal domain. As in the subunit rotation model 
(see Figure 1.9) the model proposes that the DNA is on the outside of the synaptic 
structure, but this model requires that only part of the protein rotates with the DNA via the 
hinge mechanism, and thus the 1,2 dimer interface created by the paired E-helices is 
maintained. A reduction of the H-bonding in this area by the D102Y mutant resolvase 
may allow this hinge a greater degree of flexibility.
A second possibility is that the protein is displaying an enhanced level of synapsis by 
forming a more stable synaptic complex. In assays for synapsis, substrates with an 
isolated site I and a full res give only traces of synaptic complex (Watson, 1994). A 
mutant resolvase with enhanced synapsis capability might increase the recombination
Figure 7.4 Illustration of the positions of D102 and E124
Serine-10 on each monomer is coloured red, while E l02 is blue and E l24 is 
yellow. El 24 of the green subunit lies in close proximity to S10 of the 
purple subunit, while E l02 is the residue furthest from the DNA and points 
into space on one monomer.
Figure 7.5 Diagram of the interaction of E l02 and K105
Position 102 is highlighted in blue while position 105 is highlighted in orange. On 
one y8 resolvase m onom er (coloured in green) these seem to be m aking an ionic 
interaction.
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activity on an isolated site I. This may be due to dimer-dimer interactions making the 
protein “stickier”. This suggests the possibility that position 102 exists on the as yet 
unlocated dimer-dimer interface, predicted by both the subunit and catalytic domain 
rotation models of strand exchange, and that the mutation to the more hydrophobic 
tyrosine side-chain increases the stability of the interface.
A third possibility is that the D102Y mutant resolvase has an increased ability to utilise 
non-specific DNA in the plasmid to perform the necessary wrapping of sites II and m  in 
order to form the productive synapse. It has been shown that wild-type resolvase can, to 
a certain extent, utilise non-specific DNA in order to wrap sites II and HI in the necessary 
conformation (Bednarz et al., 1990). In order to carry* this out, sites II and HI must be 
present on at least one of the two recombining sites. Since D102Y resolvase has been 
shown to produce a (-2) catenane as the product in vitro from a plasmid containing res v 
site I, it is probable that it is utilising non-specific DNA to wrap together with sites II and 
m  of the full res, to create the required 3 interdomainal supercoils. This suggests that 
D102Y resolvase may have enhanced binding activity on non-specific DNA. Binding 
studies to a full res site have indicated binding comparable to that of the wild type protein. 
A "stickier" dimer-dimer interface as suggested above, might also stabilise a synapse 
containing non-specific DNA by helping to hold all the pieces of the structure together.
7.3 Developments of this project
Because of the potential significance of resolvase mutations which confer a "hyperactive" 
phenotype, a considerable amount of further related work has been carried out since the 
completion of this project. Further in vivo screenings of a new mutant library 
(constructed in a similar manner to LI and L2) have led to the isolation of 12 mutants 
with the ability to catalyse the reaction between a site I and res (M. Burke, personal 
communication). All these resolvase mutants contain a mutation at position 102, though 
some are in conjunction with additional amino acid substitutions. The closest aspartate to 
position 102, D100, has also been mutated to a tyrosine (M Burke, personal 
communication). It is interesting to note that this mutant, D100Y is in vivo less 
recombinationally active than the wild-type protein, and is inactive on a res v site I
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substrate. Thus the equivalent mutation of the other aspartate on this surface of the 
protein does not produce the hyperactive phenotype.
Saturation mutagenesis at position 102 has indicated that substitution of aspartate by 
isoleucine, tyrosine, phenylalanine and to some extent valine and threonine causes 
hyperactive behaviour (M. Burke, personal communtcation). The mutants catalyse the 
reaction between a site I and res in vivo. All other amino acid changes (with the 
exception of methionine, tryptophan, proline and asparagine mutants which have not yet 
been isolated) give resolvases which are as recombinationally active as the wild-type 
protein in the in vivo assay. It seems unusual that a position which can yield a number of 
catalytically enhanced mutants can accommodate a wide range of amino acids which only 
enhance or at the very worst retain the function of the protein,and do not seem to have a 
detrimental effect on its catalytic ability. From the range of hyperactive mutants isolated, 
is seems that neither the charge nor the hydrophobic nature of the amino acid is 
responsible for its behaviour. Although the most hyperactive mutants have bulky rather 
hydrophobic side-chains, the D102L mutant is not hyperactive.
D102Y resolvase has been shown to have activity on a site I v site I substrate in a seperate 
in vivo assay (Martin Boocock, personal communication). The substrate in this assay 
contains a StrA gene, causing naturally streptomycin resistant cells to be streptomycin 
sensitive. The presence of a second plasmid expressing "active" resolvase excises this 
gene, in the same manner as previously described for the galK in vivo assay. The loss of 
this gene returns the cell to a streptomycin resistant phenotype which can be detected by 
patching colonies onto agar plates containing streptomycin. Using a substrate containing 
two site I's and StrA gene, this assay has shown D102Y resolvase to carry out the site I v 
site I reaction at a very low level. Analysis of the products of this reaction by agarose gel 
electrophoresis has shown the reaction to proceed at approximately 5 -10%.
A double mutant of Tn3 resolvase, containing D102Y and E124Q mutations has been 
constructed (M. Boocock, personal communication). Using the galK in vivo assay, the 
double mutant has been shown to resolve a substrate plasmid containing two site I's 
(pDB35). After purification of the mutant resolvase, studies have shown that it retains 
this phenotype in vitro, promoting recombination between two site I's on a plasmid.
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Agarose gel electrophoresis has shown both resolution and inversion products from this 
reaction, though the topology of these products has not yet been analysed. This would 
seem to suggest that the removal of sites II and IE on both the recombining sites has 
effectively removed the previous strict specificity of this system for resolution.
This double mutant is also active on site I oligonucleotides; this will hopefully prove 
useful for mechanism studies, where chemically modified oligonucleotides can be used.
7.4 Future considerations
Overall, there still remains the question of the function of the accessory sites II and El.
Do they perhaps perform a regulatory function controlling recombination at site I? If so, 
then mutation at D102Y may have removed such a control mechanism. More specifically, 
in what way have the changes we introduced altered or removed this mechanism, and 
how do we find this out?
If we consider that the mutation of aspartate to tyrosine at position 102 is resulting in a 
"sitckier" interface, possibly on a dimer-dimer interface not yet discovered, then this may 
be causing the protein to form a tetramer in solution. Gel filtration proved pivotal in 
determining that resolvase existed as a dimer in solution. With the use of suitable size 
markers, gel filtration may determine the existance of a tetramer of D102Y resolvase in 
solution.
If D102Y resolvase contains a more flexible hinge mechanism allowing the N-terminal of 
resolvase a greater freedom of movement then cysteine mutants may prove useful. 
Strategically positioned cysteine mutants, forming disulphide bridges which would 
essentially "fix" the position of the N-terminal domain would be useful in determining the 
validity of this proposal, and of the catalytic domain rotation model of strand exchange.
If however, the mutant is displaying enhanced levels of synapsis, then synaptic studies 
using the method previously used in this laboratory (Watson, 1994), may be useful.
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